covid-19 |
123 |
humans |
112 |
sars-cov-2 |
94 |
female |
82 |
male |
81 |
adult |
80 |
coronavirus |
67 |
middle aged |
64 |
animals |
55 |
hong kong - epidemiology |
48 |
child |
44 |
adolescent |
41 |
aged |
41 |
child, preschool |
40 |
infant |
40 |
influenza |
40 |
hong kong |
38 |
phylogeny |
38 |
molecular sequence data |
36 |
base sequence |
35 |
cell line |
35 |
antiviral |
33 |
disease outbreaks |
33 |
polymerase chain reaction |
32 |
sars-cov |
32 |
mice |
31 |
reverse transcriptase polymerase chain reaction |
30 |
time factors |
30 |
retrospective studies |
29 |
viral load |
29 |
genotype |
28 |
incidence |
28 |
risk factors |
28 |
sequence analysis, dna |
28 |
transmission |
28 |
interferon |
27 |
rna, viral - genetics |
27 |
treatment |
27 |
sensitivity and specificity |
26 |
china |
25 |
china - epidemiology |
25 |
flavivirus |
25 |
lipidomics |
25 |
epidemiology |
24 |
mutation |
24 |
sars |
24 |
zika |
24 |
genome, viral |
23 |
human |
23 |
medical sciences |
23 |
pathogenesis |
23 |
prospective studies |
23 |
aged, 80 and over |
22 |
antibodies, viral - blood |
22 |
bone marrow transplantation - adverse effects |
22 |
mouse |
22 |
treatment outcome |
22 |
viral replication |
22 |
amino acid sequence |
21 |
bone marrow transplantation |
21 |
diagnosis |
21 |
enterovirus |
21 |
hemagglutinin |
21 |
microbial sensitivity tests |
21 |
survival rate |
21 |
temperature |
21 |
animal |
20 |
bat |
20 |
biomarkers |
20 |
children |
20 |
chiroptera - virology |
20 |
h7n9 |
20 |
immunocompromised host |
20 |
influenza virus |
20 |
molecular epidemiology |
20 |
pandemic |
20 |
ace2 |
19 |
feces - virology |
19 |
h5n1 |
19 |
severe acute respiratory syndrome |
19 |
susceptibility |
19 |
vaccine |
19 |
antibody |
18 |
blotting, western |
18 |
cohort studies |
18 |
influenza, human - epidemiology - virology |
18 |
mers-cov |
18 |
metabolomics |
18 |
mucosal immunity |
18 |
neutralizing antibody |
18 |
novel |
18 |
prognosis |
18 |
receptor binding domain |
18 |
age factors |
17 |
anti-bacterial agents - pharmacology |
17 |
burkholderia pseudomallei |
17 |
enzyme-linked immunosorbent assay |
17 |
fatal outcome |
17 |
follow-up studies |
17 |
influenza, human - virology |
17 |
inhibitor |
17 |
mutation - genetics |
17 |
nasopharynx - virology |
17 |
seasons |
17 |
birds - virology |
16 |
convalescence |
16 |
cytokine |
16 |
dna primers |
16 |
dogs |
16 |
evolution, molecular |
16 |
fatty acid |
16 |
genetic variation |
16 |
influenza a virus |
16 |
influenza a virus, h1n1 subtype - immunology |
16 |
melioidosis |
16 |
polymerase chain reaction - methods |
16 |
sars virus - immunology |
16 |
serology |
16 |
t-lymphocytes, cytotoxic - immunology |
16 |
uplc-esi-q-tof-ms |
16 |
virus replication |
16 |
young adult |
16 |
amino acid substitution |
15 |
animal experiment |
15 |
disease outbreaks - statistics & numerical data |
15 |
genome |
15 |
immune response |
15 |
influenza, human - diagnosis - virology |
15 |
live attenuated vaccine |
15 |
neutralization tests |
15 |
pcr |
15 |
penicillium marneffei |
15 |
rat |
15 |
administration, oral |
14 |
anosmia |
14 |
bacterial typing techniques |
14 |
bronchiectasis |
14 |
cell line, tumor |
14 |
chemicals and cas registry numbers |
14 |
coronavirus - classification - genetics - isolation & purification |
14 |
diagnosis, differential |
14 |
diagnostics |
14 |
drug therapy, combination |
14 |
h1n1 |
14 |
immune activation |
14 |
infection |
14 |
influenza a |
14 |
influenza, human - immunology - pathology - virology |
14 |
intestine |
14 |
microscopy, electron |
14 |
olfactory dysfunction |
14 |
omicron |
14 |
outbreak |
14 |
pathogenicity |
14 |
plasma |
14 |
polymorphism, genetic |
14 |
protease |
14 |
replication |
14 |
species specificity |
14 |
swine - virology |
14 |
virus evolution |
14 |
virus replication - physiology |
14 |
adaptation |
13 |
age |
13 |
antibiotic prophylaxis |
13 |
bacterial proteins - genetics |
13 |
betacoronavirus |
13 |
bunyavirales |
13 |
chinese |
13 |
clarithromycin |
13 |
cluster analysis |
13 |
cytokine and chemokine response |
13 |
d222g |
13 |
disease progression |
13 |
disease reservoirs - virology |
13 |
dna, viral - genetics |
13 |
electrophoresis, gel, pulsed-field |
13 |
inactivated vaccine |
13 |
nucleoprotein |
13 |
reproducibility of results |
13 |
rhizopus microsporus |
13 |
rnai |
13 |
sace2 |
13 |
sars virus - genetics - isolation & purification |
13 |
sars-cov-2 variants |
13 |
species index: fungi |
13 |
spike protein |
13 |
transfection |
13 |
acute hepatitis |
12 |
adolescents |
12 |
animal tissue |
12 |
antiviral agents - pharmacology |
12 |
avian |
12 |
biomarker |
12 |
case report |
12 |
chronic obstructive lung disease |
12 |
controlled study |
12 |
coronavirus - genetics - isolation & purification |
12 |
coronavirus disease 2019 |
12 |
disease outbreaks - prevention & control |
12 |
dna, bacterial - genetics |
12 |
epidemics |
12 |
false positive |
12 |
flow cytometry |
12 |
infectivity |
12 |
influenza a virus, h1n1 subtype - genetics |
12 |
influenza, human - epidemiology - immunology - virology |
12 |
kawasaki disease |
12 |
lopinavir |
12 |
mice, inbred balb c |
12 |
microbiology |
12 |
mycobacterium tuberculosis |
12 |
neutralizing antibodies |
12 |
organ size |
12 |
pneumonia |
12 |
real-time pcr |
12 |
respiratory tract infections |
12 |
rna, ribosomal, 16s - genetics |
12 |
sars virus - isolation & purification |
12 |
sars-cov-2 rbd igg |
12 |
serotyping |
12 |
severe acute respiratory syndrome - diagnosis - virology |
12 |
severe acute respiratory syndrome - drug therapy |
12 |
severity of illness index |
12 |
sftsv |
12 |
staphylococcus aureus |
12 |
swine diseases - virology |
12 |
t cell response |
12 |
transcription, genetic |
12 |
urine - virology |
12 |
virulence |
12 |
2′-o-methyltransferase |
11 |
amino acid substitution - genetics |
11 |
animal cell |
11 |
animal model |
11 |
anthranilic acid |
11 |
antibodies, viral - biosynthesis |
11 |
antibody titer |
11 |
antiviral agents - chemical synthesis - chemistry - pharmacology |
11 |
bacteriological techniques - methods |
11 |
broad spectrum |
11 |
carboxypeptidases - antagonists & inhibitors - metabolism |
11 |
chemokine |
11 |
coinfection |
11 |
dna, bacterial - chemistry - genetics |
11 |
endoplasmic reticulum |
11 |
entry |
11 |
feces analysis |
11 |
genes, rrna |
11 |
graft rejection |
11 |
graft survival |
11 |
hamster |
11 |
hcov-229e |
11 |
human immunodeficiency virus |
11 |
influenza in birds - epidemiology - transmission - virology |
11 |
intradermal |
11 |
macrophages |
11 |
murine |
11 |
n501y |
11 |
nsp16 |
11 |
nucleocapsid proteins - genetics - immunology |
11 |
open reading frames - genetics |
11 |
recombination, genetic |
11 |
reverse transcriptase polymerase chain reaction - methods |
11 |
saliva |
11 |
sars coronavirus |
11 |
sars virus - drug effects - growth & development - metabolism - physiology |
11 |
sequence homology, amino acid |
11 |
seroepidemiologic studies |
11 |
sterilizing immunity |
11 |
stool |
11 |
t-cell response |
11 |
vaccination |
11 |
viral matrix proteins - antagonists & inhibitors - metabolism |
11 |
virus |
11 |
virus cultivation |
11 |
adenovirus |
10 |
airborne infection |
10 |
antigen-presentation |
10 |
autoantibody |
10 |
avian influenza |
10 |
bacteremia |
10 |
blood donors |
10 |
canada - epidemiology |
10 |
carrier state - microbiology |
10 |
cattle |
10 |
cell tropism |
10 |
chick embryo |
10 |
coronavirus - classification - genetics |
10 |
coronavirus - immunology - pathogenicity - physiology |
10 |
coronavirus infection |
10 |
coronavirus infections - immunology - virology |
10 |
covid19 |
10 |
cross reactions |
10 |
cytokines |
10 |
cytokines - biosynthesis - immunology |
10 |
cytokines - blood |
10 |
cytomegalovirus |
10 |
d225g |
10 |
damplicon |
10 |
diarrhea - epidemiology - microbiology |
10 |
diarrhea - microbiology |
10 |
disease reservoirs |
10 |
ducks - virology |
10 |
fluorescent antibody technique, indirect |
10 |
food microbiology |
10 |
genes, bacterial |
10 |
genome, bacterial |
10 |
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
human neutralizing antibody |
10 |
immunoglobulin g - blood |
10 |
immunosuppressive agents - therapeutic use |
10 |
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
influenza a virus, h1n1 subtype - isolation and purification |
10 |
influenza a virus, h1n1 subtype - physiology |
10 |
influenza a virus, h5n1 subtype - physiology |
10 |
influenza h1n1 |
10 |
influenza in birds - virology |
10 |
influenza vaccine |
10 |
influenza, human - epidemiology - transmission - virology |
10 |
injections, intramuscular |
10 |
linker-immunodominant site |
10 |
liver function tests |
10 |
lung injury |
10 |
nasal turbinate |
10 |
open reading frames |
10 |
peptide |
10 |
phage display |
10 |
picornaviridae - chemistry - classification - genetics - isolation and purification |
10 |
pneumonia, viral - immunology - virology |
10 |
respiratory system - virology |
10 |
sars virus - genetics |
10 |
sars virus - isolation and purification |
10 |
sequence homology, nucleic acid |
10 |
seroprevalence |
10 |
severe acute respiratory syndrome - virology |
10 |
sialic acid |
10 |
specific |
10 |
swine-origin |
10 |
t-lymphocytes - immunology |
10 |
upper respiratory tract |
10 |
virology |
10 |
virus shedding |
10 |
5' untranslated regions |
9 |
acute disease |
9 |
adenosine synthase a |
9 |
aged mice |
9 |
airway organoid |
9 |
alleles |
9 |
anti-bacterial agents - therapeutic use |
9 |
antibody-dependent cell-mediated cytotoxicity |
9 |
antigens, viral - analysis |
9 |
antitubercular agents - therapeutic use |
9 |
antiviral agents - administration and dosage - therapeutic use |
9 |
apoptosis |
9 |
asia, southeastern |
9 |
ba.5.2 |
9 |
bacteriological techniques |
9 |
bagg albino mouse |
9 |
bioaerosols |
9 |
bocavirus - classification - genetics - isolation and purification |
9 |
celecoxib |
9 |
cell surface |
9 |
clinical outcome |
9 |
comorbidity |
9 |
convalescent |
9 |
coronavac |
9 |
coronavirus infections - genetics |
9 |
covid‐19 |
9 |
cross infection - epidemiology - immunology |
9 |
cross protection |
9 |
cytopathogenic effect, viral |
9 |
dogs - virology |
9 |
drug resistance, bacterial |
9 |
drug resistance, bacterial - genetics |
9 |
emerging |
9 |
ex vivo |
9 |
fc-rbd |
9 |
gram-negative bacterial infections - diagnosis - microbiology |
9 |
h1n1 influenza virus |
9 |
hku1 |
9 |
hospitals, university |
9 |
human adenovirus |
9 |
human primary nasal epithelial cells |
9 |
illumina sequencing |
9 |
immune protection |
9 |
immunization |
9 |
immunoglobulin g - analysis - immunology |
9 |
immunohistochemistry |
9 |
infant, newborn |
9 |
influenza a virus, h1n1 subtype - genetics - isolation and purification - physiology |
9 |
influenza vaccines - administration and dosage |
9 |
internalization |
9 |
laribacter hongkongensis |
9 |
liver diseases - epidemiology |
9 |
liver transplantation - statistics & numerical data |
9 |
lung - radiography |
9 |
lung damage |
9 |
membrane glycoproteins - analysis |
9 |
membrane glycoproteins - chemistry - genetics |
9 |
membrane glycoproteins - immunology |
9 |
mers |
9 |
mesalazine |
9 |
middle east respiratory syndrome coronavirus |
9 |
model |
9 |
mrsa |
9 |
myocardial infarction - mortality - prevention and control |
9 |
novel species |
9 |
nucleocapsid proteins - genetics |
9 |
nucleolin |
9 |
omicron variant |
9 |
operating rooms |
9 |
orchitis |
9 |
orthomyxoviridae infections - immunology - mortality - physiopathology - virology |
9 |
oseltamivir |
9 |
parvoviridae infections - veterinary - virology |
9 |
phenotype |
9 |
phosphatidic acid phosphatases |
9 |
pneumococcal vaccines - administration and dosage |
9 |
pneumonia, viral - epidemiology - immunology - virology |
9 |
pneumonia, viral - virology |
9 |
point-of-care testing |
9 |
polymorphism, single nucleotide |
9 |
post-ba.2/5 subvariants |
9 |
proximal differentiation |
9 |
recombinant proteins - analysis - immunology |
9 |
respiratory |
9 |
respiratory tract infection |
9 |
resting-state fmri |
9 |
rhinovirus |
9 |
ribosomes - genetics - metabolism |
9 |
rna interference |
9 |
sars-cov-2 variants of concern |
9 |
sars‐cov‐2 |
9 |
sequence alignment |
9 |
seroepidemiology |
9 |
severe acute respiratory syndrome - epidemiology - immunology - virology |
9 |
severe acute respiratory syndrome - epidemiology - transmission - virology |
9 |
severe acute respiratory syndrome - immunology - virology |
9 |
smell impairment |
9 |
steroid |
9 |
stroke - mortality - prevention and control |
9 |
swine |
9 |
talaromyces marneffei |
9 |
testis |
9 |
tissue donors |
9 |
transplantation, homologous - adverse effects |
9 |
vaccination - methods |
9 |
vaccines, dna - administration & dosage - immunology |
9 |
viral envelope proteins - analysis |
9 |
viral envelope proteins - chemistry - genetics |
9 |
viral envelope proteins - genetics - immunology |
9 |
viral proteins - genetics |
9 |
vitamin a |
9 |
vopba |
9 |
weanling mice |
9 |
xbb.1 |
9 |
zanamivir |
9 |
zika virus |
9 |
zoonosis |
9 |
2009 h1n1 influenza |
8 |
25-hydroxycholesterol |
8 |
3clpro inhibitor |
8 |
a(h1n1)pdm09 |
8 |
a(h3n2) |
8 |
adjuvant |
8 |
aerosolised |
8 |
allosteric-site inhibitor |
8 |
am580 |
8 |
animal models |
8 |
antibodies, neutralizing - blood |
8 |
antibody blood level |
8 |
antibody detection |
8 |
antibody formation |
8 |
antibody response |
8 |
antifungal agents - therapeutic use |
8 |
antiviral agents - therapeutic use |
8 |
aspergillus |
8 |
aspergillus fumigatus |
8 |
asymptomatic |
8 |
asymptomatic infection |
8 |
autopsy |
8 |
avian influenza virus |
8 |
b cell |
8 |
b-cell suppression |
8 |
bacteremia - microbiology |
8 |
biliary atresia - complications - surgery |
8 |
binding sites |
8 |
biology |
8 |
biotechnology technology: comprehensive works medical sciences chemistry |
8 |
bone marrow transplantation - immunology |
8 |
broad-spectrum antiviral treatment |
8 |
case study |
8 |
case-control studies |
8 |
caspase |
8 |
chemical genetics |
8 |
chi-square distribution |
8 |
chicken |
8 |
cloning, molecular |
8 |
clostridium difficile |
8 |
combination therapy |
8 |
complications of liver transplantation |
8 |
conjunctiva |
8 |
coronavirus - immunology |
8 |
coronavirus hku1 |
8 |
coronavirus infections - epidemiology - physiopathology - virology |
8 |
cross-reactive |
8 |
cyclosporine - therapeutic use |
8 |
cytokines - genetics - metabolism |
8 |
databases, nucleic acid - statistics & numerical data |
8 |
delns1-ncov-rbd laiv |
8 |
detection |
8 |
diagnostic |
8 |
dialysis |
8 |
dipeptidyl peptidase 4 |
8 |
dna, viral - chemistry - genetics |
8 |
dog diseases - virology |
8 |
dromedary camel |
8 |
drug synergism |
8 |
early diagnosis |
8 |
emc |
8 |
fishes - microbiology |
8 |
functional brain network |
8 |
ganglioside gm1 antibody |
8 |
gastroenteritis |
8 |
gastroenteritis - microbiology |
8 |
gastrointestinal diseases - microbiology |
8 |
gene deletion |
8 |
gene expression regulation, bacterial |
8 |
gene silencing |
8 |
genetics |
8 |
genome, fungal |
8 |
glycolipids |
8 |
gram-positive bacterial infections - microbiology |
8 |
hcov-emc |
8 |
hemagglutination inhibition tests |
8 |
hepatitis b vaccination |
8 |
high throughput screening |
8 |
hospitalized |
8 |
human rhinovirus |
8 |
hypsugo bat |
8 |
il-8 |
8 |
imiquimod |
8 |
immunization schedule |
8 |
immunization, secondary |
8 |
immunocompetence |
8 |
infection control |
8 |
influenza a virus, h1n1 subtype - genetics - immunology - isolation and purification |
8 |
influenza a virus, h1n1 subtype - genetics - isolation & purification - physiology |
8 |
influenza a virus, h1n1 subtype - immunology - pathogenicity |
8 |
influenza a virus, h1n1 subtype - isolation & purification - pathogenicity |
8 |
influenza a virus, h5n1 subtype - immunology - pathogenicity |
8 |
influenza a virus, h5n1 subtype - isolation & purification - pathogenicity |
8 |
influenza vaccines - immunology |
8 |
influenza, human - epidemiology - pathology - virology |
8 |
influenza, human - epidemiology - prevention & control - transmission - virology |
8 |
influenza, human - immunology |
8 |
integrative-omics |
8 |
interferon lambda 1 |
8 |
interventions |
8 |
intranasal |
8 |
intraoperative complications - epidemiology |
8 |
leukocytes - virology |
8 |
lipid |
8 |
liver diseases - etiology - surgery |
8 |
liver transplantation - adverse effects - statistics & numerical data |
8 |
liver transplantation - contraindications - methods - mortality - statistics & numerical data |
8 |
liver transplantation - methods |
8 |
living donor liver transplant |
8 |
living-related liver transplantation |
8 |
long covid |
8 |
marmosets |
8 |
mask |
8 |
membrane glycoproteins - genetics |
8 |
membrane glycoproteins - metabolism |
8 |
metabolomic |
8 |
metalloimmunity |
8 |
metalloproteomics |
8 |
methicillin resistance |
8 |
meticillin-resistant staphylococcus aureus |
8 |
mice, inbred c57bl |
8 |
microbial sensitivity tests - methods |
8 |
mitochondrial dysfunction |
8 |
nanopore sequencing |
8 |
naproxen |
8 |
neutralization |
8 |
ns5 |
8 |
nsp1 |
8 |
nucleic acid amplification techniques - methods |
8 |
nucleic acid conformation |
8 |
nucleocapsid proteins - immunology |
8 |
obesity |
8 |
oc43 |
8 |
older patients |
8 |
olfactory training |
8 |
organic acid |
8 |
pediatric liver transplant |
8 |
penicillium - genetics |
8 |
phase-1 |
8 |
phospholipids |
8 |
phylogenetic tree |
8 |
plasmids |
8 |
pneumococcal vaccination |
8 |
point mutation |
8 |
portoenterostomy, hepatic |
8 |
postoperative complications |
8 |
postoperative complications - classification - epidemiology |
8 |
postoperative complications - epidemiology |
8 |
poultry |
8 |
promoter regions, genetic |
8 |
randomized controlled trial |
8 |
rats |
8 |
real-time rt-pcr |
8 |
receptor, interferon alpha-beta - genetics |
8 |
recombination |
8 |
reduced-size liver transplant |
8 |
reduced-size liver transplantation |
8 |
reoperation |
8 |
respiratory tract infections - epidemiology - physiopathology - virology |
8 |
respiratory tract infections - virology |
8 |
reverse genetics |
8 |
rna, viral - analysis |
8 |
rna, viral - analysis - genetics |
8 |
rt-pcr |
8 |
rt‐pcr |
8 |
sars virus |
8 |
screening |
8 |
seizures, febrile - epidemiology |
8 |
sequencing |
8 |
serial |
8 |
serial passage |
8 |
shedding |
8 |
singapore - epidemiology |
8 |
smell loss |
8 |
sphingolipids |
8 |
spike |
8 |
spike glycoprotein |
8 |
spike mutant |
8 |
spike s1/s2 mutant |
8 |
spleen |
8 |
staphylococcal infections - microbiology |
8 |
t lymphocytes |
8 |
tissue donors - statistics & numerical data |
8 |
tlr7 agonist |
8 |
tonsil |
8 |
urine |
8 |
vancomycin-resistant enterococci |
8 |
vietnam - epidemiology |
8 |
viral envelope proteins - metabolism |
8 |
viral load - physiology |
8 |
viral matrix proteins - genetics |
8 |
viral proteins - chemistry - genetics |
8 |
virus replication - drug effects |
8 |
5′-race assay |
7 |
a(h1n1)pdm09 influenza |
7 |
a(h7n9) influenza |
7 |
activities of daily living |
7 |
acute infection |
7 |
adaptation, physiological - genetics |
7 |
adiponectin |
7 |
adoptive transfer |
7 |
anastomosis, roux-en-y |
7 |
anastomosis, surgical - methods |
7 |
anti-bacterial agents - pharmacology - therapeutic use |
7 |
antibiotic resistance |
7 |
antibodies, monoclonal - immunology |
7 |
antibodies, viral - blood - immunology |
7 |
antibodies, viral - genetics - immunology - metabolism |
7 |
antibody specificity |
7 |
antiviral compounds |
7 |
arthritis, infectious - microbiology |
7 |
autoclave |
7 |
avian influenza a/h7n9 virus |
7 |
bacteraemia |
7 |
bacteremia - diagnosis - microbiology |
7 |
bile duct diseases - etiology |
7 |
bile ducts - blood supply - surgery |
7 |
biliary atresia |
7 |
bilirubin - blood |
7 |
biopsy |
7 |
bird diseases - virology |
7 |
bk virus - isolation & purification |
7 |
blotting, southern |
7 |
bocaparvovirus |
7 |
bocavirus - classification - genetics - isolation & purification |
7 |
body weight |
7 |
broad-spectrum |
7 |
broadly neutralizing antibody |
7 |
bromocriptine |
7 |
caco-2 |
7 |
candida |
7 |
cats |
7 |
cattle - virology |
7 |
cattle diseases - virology |
7 |
cell culture |
7 |
chlorogenic acid - chemistry - pharmacology |
7 |
clade |
7 |
clinic |
7 |
colony count, microbial |
7 |
common cold - genetics |
7 |
common cold - virology |
7 |
community-acquired-infections-epidemiology |
7 |
community-acquired-infections-mortality |
7 |
community-acquired-infections-physiopathology |
7 |
community-acquired-infections-virology |
7 |
coronaviridae - classification - genetics - isolation and purification |
7 |
coronaviridae infections - veterinary - virology |
7 |
coronavirus - classification - genetics - immunology - metabolism |
7 |
coronavirus 229e, human - genetics - physiology |
7 |
coronavirus infections - epidemiology - immunology |
7 |
coronavirus infections - virology |
7 |
coronavirus oc43, human - classification - genetics - isolation and purification |
7 |
coronavirus-genetics |
7 |
corticosteroid |
7 |
cricetinae |
7 |
culture media |
7 |
culture media - chemistry |
7 |
cva16 |
7 |
defective interfering viral genome |
7 |
dendritic cell |
7 |
dendritic cells |
7 |
dental |
7 |
directly observed |
7 |
discovery |
7 |
disease severity |
7 |
diversity |
7 |
dna fingerprinting |
7 |
dna, bacterial - analysis |
7 |
dna, ribosomal - analysis |
7 |
dna, ribosomal - chemistry - genetics |
7 |
down-regulation |
7 |
enterovirus d68 |
7 |
enzyme activation |
7 |
epidemiology, molecular |
7 |
escherichia coli |
7 |
etiology |
7 |
ev-a71 |
7 |
evaluation |
7 |
face masks |
7 |
fecal |
7 |
fish diseases - microbiology |
7 |
flavonoids - chemistry - pharmacology |
7 |
fluorescein-5-isothiocyanate - metabolism |
7 |
fluorescent dyes - metabolism |
7 |
fungus protein |
7 |
furin cleavage prra motif |
7 |
furin inhibitor |
7 |
gastroenteritis - epidemiology - microbiology |
7 |
gastroenteritis - epidemiology - physiopathology - virology |
7 |
gene |
7 |
genes, bacterial - genetics |
7 |
genetic predisposition to disease |
7 |
genetic vectors |
7 |
genetic vectors - genetics |
7 |
genomic sequence |
7 |
genomics |
7 |
glycoprotein |
7 |
glycosylation |
7 |
glycyrrhizic acid - chemistry - pharmacology |
7 |
h7n7 virus |
7 |
hand hygiene |
7 |
handwashing - methods |
7 |
hbv infection |
7 |
hela cells |
7 |
hemagglutinins - genetics |
7 |
hematopoietic stem cell transplantation - adverse effects |
7 |
hemolysis |
7 |
hepatic artery - surgery |
7 |
hepatic encephalopathy - surgery |
7 |
hepatitis - surgery |
7 |
hepatitis b virus |
7 |
hepatitis b, chronic - genetics - immunology - metabolism |
7 |
high infection rate |
7 |
histocompatibility |
7 |
human coronavirus hku1 |
7 |
icu patient |
7 |
ifnar1 |
7 |
immunity |
7 |
immunology |
7 |
immunosuppression - adverse effects |
7 |
immunotherapy - methods |
7 |
infection control - methods |
7 |
infectious disease |
7 |
influenza, human - drug therapy - epidemiology - virology |
7 |
injections, intraperitoneal |
7 |
interferon antagonist |
7 |
interferon-alpha - pharmacology |
7 |
interferon-beta - pharmacology |
7 |
interspecies |
7 |
intestinal organoids |
7 |
ire1 |
7 |
kidney - cytology |
7 |
klebsiella infections - epidemiology - microbiology |
7 |
klebsiella oxytoca - classification - genetics - isolation and purification - pathogenicity |
7 |
length of stay |
7 |
leptin |
7 |
life cycle |
7 |
lightmix e-gene |
7 |
liver diseases - congenital - mortality - surgery |
7 |
liver failure - surgery |
7 |
liver transplantation - adverse effects - methods - mortality |
7 |
liver transplantation - adverse effects - methods - pathology - statistics & numerical data |
7 |
liver transplantation - methods - physiology |
7 |
liver transplantation - mortality |
7 |
living donors |
7 |
living donors - classification |
7 |
lung eqtl |
7 |
mammals - virology |
7 |
maturation |
7 |
mdms |
7 |
membrane glycoproteins - genetics - immunology |
7 |
membrane glycoproteins - genetics - immunology - metabolism |
7 |
mers coronavirus |
7 |
methicillin-resistant staphylococcus aureus |
7 |
methicillin-resistant staphylococcus aureus - isolation and purification |
7 |
microsurgery |
7 |
microvascular anastomosis |
7 |
miltefosine |
7 |
modcs |
7 |
models, molecular |
7 |
monoinfection |
7 |
ms |
7 |
multigene family |
7 |
multivariate analysis |
7 |
mutation, missense |
7 |
mycological typing techniques - methods |
7 |
nasopharynx/virology |
7 |
native conformation |
7 |
neisseriaceae - genetics |
7 |
neisseriaceae - genetics - isolation & purification |
7 |
neurogenesis |
7 |
neutralization antibody |
7 |
nglycosylation |
7 |
nlrp3 inflammasome |
7 |
nsp3 |
7 |
nucleocapsid - analysis |
7 |
olfactory neuron |
7 |
orf6 |
7 |
oseltamivir - administration and dosage - therapeutic use |
7 |
pa protein |
7 |
parvoviridae infections - epidemiology - physiopathology - virology |
7 |
parvovirinae - classification - genetics - isolation and purification |
7 |
parvovirus - classification - genetics - isolation and purification |
7 |
parvovirus - genetics - isolation and purification |
7 |
pediatric liver transplantation |
7 |
phylodynamic |
7 |
phylogenetic |
7 |
physiological processes - genetics |
7 |
plasmids - genetics |
7 |
plpro |
7 |
polymorphism, restriction fragment length |
7 |
postoperative complications - prevention & control |
7 |
postoperative complications - prevention & control - surgery |
7 |
predictive value of tests |
7 |
pregnancy |
7 |
preoperative care |
7 |
prevalence |
7 |
protein structure, tertiary |
7 |
proteome |
7 |
pyrimidinones - pharmacology |
7 |
recombinant proteins - immunology - metabolism |
7 |
registries |
7 |
reinfection |
7 |
remdesivir |
7 |
respiratory tract infections - epidemiology - virology |
7 |
respiratory virus |
7 |
respiratory viruses |
7 |
rhinovirus - classification - genetics |
7 |
ribavirin - pharmacology |
7 |
rimantadine - pharmacology |
7 |
risk assessment |
7 |
rna, bacterial - genetics |
7 |
rna, messenger - genetics - metabolism |
7 |
route of transmission |
7 |
sars cov |
7 |
sars virus - chemistry |
7 |
sars virus - classification - genetics - isolation & purification |
7 |
sars virus - drug effects |
7 |
sars virus - genetics - immunology |
7 |
sars virus - genetics - physiology |
7 |
sepsis - prevention & control |
7 |
severe |
7 |
severe acute respiratory syndrome - blood - physiopathology - urine - virology |
7 |
severe acute respiratory syndrome - diagnosis |
7 |
severe acute respiratory syndrome - genetics |
7 |
sheep - virology |
7 |
single molecule real time sequencing |
7 |
single-tube nested |
7 |
small-molecule inhibitor |
7 |
snp |
7 |
spermatogenesis |
7 |
stability |
7 |
stents |
7 |
sterilization |
7 |
subgenomic transcripts |
7 |
surface expression |
7 |
t cell responses |
7 |
tfh |
7 |
thrombosis - prevention & control |
7 |
tmprss2 |
7 |
transcription regulation |
7 |
travel |
7 |
uhplc |
7 |
untranslated |
7 |
upr |
7 |
vascular surgical procedures - methods |
7 |
viral envelope proteins - genetics - immunology - metabolism |
7 |
viral genome |
7 |
viral isolation |
7 |
viral plaque assay |
7 |
viral proteins - blood - genetics |
7 |
viral variants |
7 |
virulence factors |
7 |
virus maturation |
7 |
whole-genome sequencing |
7 |
zoonoses |
7 |
2019 novel coronavirus |
6 |
3' untranslated regions |
6 |
acquired immunodeficiency syndrome - complications - etiology |
6 |
acupuncture therapy - adverse effects |
6 |
air sampling |
6 |
amantadine-pharmacology |
6 |
amoxicillin-potassium clavulanate combination - administration & dosage |
6 |
amoxicillin-potassium clavulanate combination - therapeutic use |
6 |
anaerobic bacteria |
6 |
animals, domestic |
6 |
animals, domestic - microbiology |
6 |
animals, wild - virology |
6 |
anti-bacterial agents |
6 |
antibody assay |
6 |
antigen |
6 |
antigenic cartography |
6 |
antigenic distance |
6 |
antigenic field |
6 |
ar-12 |
6 |
arachidonic acid |
6 |
arbovirus |
6 |
artenimol |
6 |
aspergillus hongkongensis sp. nov. |
6 |
astrovirus |
6 |
autoantibodies - blood |
6 |
automated |
6 |
bacteremia - complications - microbiology |
6 |
bacteremia - diagnosis |
6 |
bacteremia - epidemiology - microbiology |
6 |
bacteria, aerobic - classification - genetics - isolation and purification |
6 |
bacterial proteins |
6 |
bacterial vaccines - administration & dosage - immunology |
6 |
bacterium |
6 |
base composition |
6 |
bat screening |
6 |
bile |
6 |
biliary |
6 |
biomedicine |
6 |
bird diseases - epidemiology - virology |
6 |
blood - microbiology |
6 |
blood culture |
6 |
bmt |
6 |
booster vaccine |
6 |
bowel preparation |
6 |
brain |
6 |
bronchi - pathology |
6 |
broxyquinoline |
6 |
burkholderia infections - etiology - immunology |
6 |
cancer |
6 |
candida tropicalis fungaemia |
6 |
carcinoma |
6 |
carnivora - virology |
6 |
cat diseases - virology |
6 |
cell nucleus - ultrastructure |
6 |
cellulitis - microbiology |
6 |
chickens - immunology |
6 |
cholangiocarcinoma |
6 |
cholangitis |
6 |
clarithromycin - adverse effects - contraindications |
6 |
cloning, molecular - methods |
6 |
clr |
6 |
co-evolution |
6 |
co-immunoprecipitation |
6 |
colchicine - adverse effects - contraindications |
6 |
common marmoset |
6 |
communicable diseases |
6 |
community |
6 |
computational biology - methods |
6 |
coronaviridae - classification - genetics - isolation & purification |
6 |
coronavirus - classification - genetics - immunology - isolation & purification |
6 |
coronavirus - classification - isolation & purification - ultrastructure |
6 |
coronavirus - physiology |
6 |
coronavirus 229e, human - immunology |
6 |
coronavirus infections - diagnosis - transmission - virology |
6 |
coronavirus infections - veterinary - virology |
6 |
coronavirus oc43, human - immunology |
6 |
cost |
6 |
covid-19 vaccine |
6 |
coxsackievirus a6 |
6 |
cross infection - complications |
6 |
cross infection - microbiology |
6 |
crossing over, genetic |
6 |
crystal structure |
6 |
daptomycin |
6 |
decolonization |
6 |
diagnostic assay |
6 |
dimorphic fungus |
6 |
disease reservoirs - veterinary - virology |
6 |
diverse |
6 |
dna vaccine |
6 |
dna, bacterial - chemistry - isolation & purification |
6 |
dna, ribosomal - chemistry - isolation & purification |
6 |
dna, viral - blood |
6 |
drug interactions |
6 |
drug resistance, microbial |
6 |
drug resistance, viral |
6 |
drug therapy, combination - therapeutic use |
6 |
drug-resistance,-viral-genetics |
6 |
ducks - immunology |
6 |
elderly |
6 |
elisa |
6 |
eltrombopag |
6 |
enterovirus 71 |
6 |
enterovirus a, human - classification - genetics - isolation & purification |
6 |
envelope |
6 |
environmental microbiology |
6 |
enzymatic immunoassay |
6 |
enzyme-linked immunosorbent assay - methods |
6 |
eosinophil |
6 |
epithelial cells - virology |
6 |
escherichia coli proteins |
6 |
face mask |
6 |
far east - epidemiology |
6 |
feces - microbiology |
6 |
food contamination - analysis |
6 |
gastroenteritis - epidemiology - virology |
6 |
geese - immunology |
6 |
gene expression regulation, fungal |
6 |
gene frequency |
6 |
genes, rrna - genetics |
6 |
genes, viral - genetics |
6 |
genes, viral/ - genetics |
6 |
genome subtraction |
6 |
genotyping |
6 |
giant cells - ultrastructure |
6 |
graft vs host disease - immunology |
6 |
gram-negative bacteria - classification - genetics - isolation and purification |
6 |
gram-positive bacteria - isolation & purification |
6 |
gram-positive bacterial infections - epidemiology - microbiology - mortality - physiopathology |
6 |
guanosine |
6 |
guidelines as topic |
6 |
haematological malignancies |
6 |
haemorrhagic cystitis |
6 |
hand, foot and mouth disease - epidemiology - virology |
6 |
hand-foot-and-mouth disease |
6 |
health care workers |
6 |
heat-shock response - genetics |
6 |
hedgehog |
6 |
hemagglutinin glycoproteins, influenza virus - chemistry - genetics |
6 |
hemagglutinins, viral - metabolism |
6 |
hepatitis |
6 |
hepatitis b - therapy |
6 |
hepatitis b, chronic - genetics |
6 |
hepatitis c virus |
6 |
hepatitis e |
6 |
hev-c1 |
6 |
hexachlorophene |
6 |
hiv protease inhibitors - therapeutic use |
6 |
hla-c antigens - genetics - metabolism |
6 |
host-targeted antiviral |
6 |
hpyv6 |
6 |
hsp90β |
6 |
huaiyangshan banyangvirus |
6 |
human rhinovirus c |
6 |
immune imprinting |
6 |
immune tolerance |
6 |
immunoassay - methods |
6 |
immunogenicity |
6 |
infections |
6 |
influenza a virus, h1n1 subtype - genetics - immunology |
6 |
influenza a virus, h1n1 subtype - metabolism |
6 |
influenza a virus, h5n1 subtype - immunology - isolation & purification |
6 |
influenza a virus, h5n1 subtype - isolation & purification |
6 |
influenza a virus, h9n2 subtype - genetics - immunology |
6 |
influenza in birds - immunology - prevention & control |
6 |
influenza vaccines - administration & dosage |
6 |
influenza-a-virus,-h5n1-subtype-drug-effects |
6 |
influenza-a-virus,-h5n1-subtype-genetics |
6 |
infusions, intravenous |
6 |
innate immune evasion |
6 |
intensive care unit |
6 |
interactome |
6 |
interferon-gamma - analysis |
6 |
interferon-gamma - immunology |
6 |
interleukin-4 - analysis |
6 |
internal medicine |
6 |
intestines - microbiology |
6 |
intra-host diversity |
6 |
kaletra |
6 |
kidney failure - complications |
6 |
kidney transplantation |
6 |
kidney transplantation - adverse effects |
6 |
kinase |
6 |
kinetics |
6 |
laboratory |
6 |
lactobacillus rhamnosus gg |
6 |
leptotrichia - classification - genetics - isolation & purification |
6 |
leptotrichia hongkongensis |
6 |
linezolid |
6 |
live-attenuated influenza-based vaccine |
6 |
liver disease |
6 |
lung - immunology - pathology - virology |
6 |
lung - pathology - virology |
6 |
macrophages - immunology - virology |
6 |
maldi-tof ms |
6 |
malignancy |
6 |
medical microbiology |
6 |
membrane glycoproteins - administration & dosage - genetics - immunology |
6 |
memory t cell |
6 |
merbecovirus |
6 |
metabolic fingerprinting |
6 |
metabolites |
6 |
metaplasia |
6 |
microcephaly |
6 |
middle east |
6 |
mincle |
6 |
mitochondrial dysfunction (md) |
6 |
models, animal |
6 |
molecular detection |
6 |
molecular diagnostic techniques - methods |
6 |
molecular modelling |
6 |
morbillivirus - pathogenicity |
6 |
mortality |
6 |
mosquito |
6 |
mouth - microbiology |
6 |
mp1p-lbd2 |
6 |
multigene family - genetics |
6 |
mycobacterium tuberculosis - isolation & purification |
6 |
mycophenolate |
6 |
mycophenolic acid |
6 |
mycoses - etiology - immunology |
6 |
nasal cavity - virology |
6 |
nasal prevention |
6 |
nasopharyngeal |
6 |
nasopharyngeal swab |
6 |
neisseriaceae - isolation & purification |
6 |
nephritis, interstitial - virology |
6 |
newly-weaned hamster |
6 |
next-generation sequencing |
6 |
nmr interaction titration |
6 |
nose - virology |
6 |
nosocomial transmission |
6 |
novobiocin |
6 |
nsp2 |
6 |
nucleic acid amplification |
6 |
nucleocapsid proteins - isolation & purification |
6 |
ofloxacin |
6 |
omacetaxine mepesuccinate |
6 |
onychomycosis |
6 |
opportunistic infections - diagnosis - transmission - virology |
6 |
orthomyxoviridae - genetics - isolation & purification - pathogenicity |
6 |
parainfluenza virus |
6 |
parainfluenza virus 4, human - classification - genetics - isolation & purification |
6 |
paramyxoviridae - classification - genetics - isolation & purification |
6 |
paramyxoviridae infections - veterinary - virology |
6 |
paramyxovirus |
6 |
parvovirus |
6 |
patient |
6 |
pd1-based dna vaccine |
6 |
pediatric |
6 |
penicillium - genetics - metabolism |
6 |
penicillium - isolation & purification |
6 |
pharynx - virology |
6 |
picornaviridae - classification - genetics - isolation & purification |
6 |
picornaviridae - classification - genetics - isolation and purification |
6 |
picornaviridae infections - epidemiology - virology |
6 |
plasma - immunology |
6 |
platelet transfusion - adverse effects |
6 |
pneumocytis |
6 |
pneumonia - diagnosis - veterinary - virology |
6 |
pneumonia - etiology |
6 |
polyethylene glycol |
6 |
polymerase inhibitor |
6 |
polyomavirus |
6 |
poultry - virology |
6 |
poultry diseases - prevention & control |
6 |
pregnancy complications, infectious - diagnosis - therapy |
6 |
premembrane |
6 |
primate |
6 |
proinflammatory response |
6 |
proinflammatory signaling lipid |
6 |
promoter regions, genetic - genetics |
6 |
psoas abscess - microbiology |
6 |
public health |
6 |
pulse therapy, drug |
6 |
pyrimidinones - therapeutic use |
6 |
quarantine - veterinary |
6 |
rapid diagnosis |
6 |
rat hepatitis e |
6 |
reagent kits, diagnostic |
6 |
real time rt-pcr |
6 |
realstar® adenovirus pcr kit |
6 |
reassortant viruses - genetics - isolation & purification - pathogenicity |
6 |
receptors, virus - genetics - metabolism |
6 |
regorafenib |
6 |
renal transplant |
6 |
respiratory syncytial virus |
6 |
reverse transcriptase polymerase chain reaction - methods - standards |
6 |
rhinovirus - classification - genetics - isolation and purification |
6 |
ribavirin |
6 |
rimantadine-pharmacology |
6 |
ritonavir - therapeutic use |
6 |
rlr |
6 |
rna, viral |
6 |
rna, viral - analysis - isolation & purification |
6 |
rna, viral - chemistry |
6 |
rna, viral - genetics - isolation & purification |
6 |
rodent |
6 |
rodents |
6 |
rt-lamp |
6 |
sarbecovirus |
6 |
sars virus - classification - genetics |
6 |
sars virus - classification - genetics - immunology - isolation & purification |
6 |
sars virus - genetics - immunology - isolation & purification |
6 |
sars virus - pathogenicity |
6 |
sars-cov-1 |
6 |
seasonality |
6 |
seizure |
6 |
sepsis |
6 |
sequence deletion |
6 |
severe acute respiratory syndrome - blood - immunology |
6 |
severe acute respiratory syndrome - complications - immunology |
6 |
severe acute respiratory syndrome - complications - pathology - virology |
6 |
severe acute respiratory syndrome - diagnosis - drug therapy - epidemiology - virology |
6 |
severe acute respiratory syndrome - diagnosis - epidemiology - virology |
6 |
severe acute respiratory syndrome - diagnosis - immunology |
6 |
severe acute respiratory syndrome - diagnosis - immunology - virology |
6 |
severe acute respiratory syndrome - diagnosis - transmission - virology |
6 |
severe acute respiratory syndrome - diagnosis - urine |
6 |
severe acute respiratory syndrome - drug therapy - virology |
6 |
severe acute respiratory syndrome - epidemiology - microbiology |
6 |
severe acute respiratory syndrome - epidemiology - virology |
6 |
severe acute respiratory syndrome - prevention & control |
6 |
sfstv |
6 |
shewanella - classification - drug effects - isolation & purification - pathogenicity |
6 |
songbirds - virology |
6 |
spa type |
6 |
species |
6 |
specimen handling |
6 |
streptococcal infections |
6 |
streptococcal infections - microbiology |
6 |
streptococcus - classification - genetics - isolation & purification |
6 |
structural evolution |
6 |
syto9 |
6 |
t-cell functionality |
6 |
tetrapeptide |
6 |
tick |
6 |
tract |
6 |
transmissibility |
6 |
transmission dynamics |
6 |
triclosan |
6 |
tuberculosis |
6 |
tuhokovirus |
6 |
vaccination - veterinary |
6 |
vaccine seed strain selection |
6 |
vaccines, synthetic - administration & dosage - immunology |
6 |
vancomycin resistance |
6 |
viral envelope proteins - administration & dosage - genetics - immunology |
6 |
viral hepatitis |
6 |
viral load - statistics & numerical data |
6 |
viral proteins - genetics - metabolism |
6 |
viral structural proteins - genetics |
6 |
viremia - diagnosis - epidemiology |
6 |
virulence mechanism |
6 |
virus attachment |
6 |
virus discovery |
6 |
whole genome |
6 |
wuhan |
6 |
zoonoses - epidemiology |
6 |
16s rdna gene |
5 |
3c-like protease |
5 |
abbott real time hcv genotype ii |
5 |
acetic acid |
5 |
acquired immunodeficiency syndrome - complications - diagnosis |
5 |
actinomyces - classification - cytology - isolation & purification - physiology |
5 |
actinomyces hongkongensis |
5 |
actinomycetales - genetics - isolation & purification |
5 |
actinomycetales - isolation & purification |
5 |
actinomycetales infections - diagnosis - microbiology |
5 |
actinomycetales infections - microbiology |
5 |
actinomycosis - microbiology |
5 |
actins - genetics |
5 |
acyclovir - therapeutic use |
5 |
adaptation, biological |
5 |
adeno-associated virus |
5 |
adenosine deaminase |
5 |
adrenal cortex hormones - administration and dosage - adverse effects |
5 |
agar block smear |
5 |
aichi virus |
5 |
alere i flu a & b |
5 |
allogeneic stem cell transplantation |
5 |
alphacoronavirus |
5 |
amniotomy |
5 |
anaerobic bacterium |
5 |
anaerobiosis |
5 |
animals, domestic - virology |
5 |
antibiotic sensitivity |
5 |
antibiotic susceptibility |
5 |
antibody affinity |
5 |
antigens, viral - analysis - immunology |
5 |
antigens, viral - blood |
5 |
antigens, viral, tumor - genetics - immunology |
5 |
antimicrobial agents/inhibitors |
5 |
antitubercular agents - pharmacology |
5 |
arachidonic acid (aa) |
5 |
arthralgia |
5 |
arthritis |
5 |
asia |
5 |
asian continental ancestry group - genetics |
5 |
aspergillosis - etiology |
5 |
aspergillus - isolation & purification |
5 |
astroviridae - classification - genetics - isolation and purification |
5 |
astroviridae infections - veterinary - virology |
5 |
b-lymphocytes - cytology - immunology - metabolism |
5 |
b.1.1.7b.1.351 |
5 |
bacteremia - complications - epidemiology - etiology |
5 |
bacteria |
5 |
bacteria (microorganisms) |
5 |
bacteria - classification - genetics |
5 |
bacteria - classification - genetics - isolation & purification |
5 |
bacteria - isolation & purification |
5 |
bacteria, aerobic - classification - genetics |
5 |
bacteria, anaerobic - classification - genetics |
5 |
bacterial endocarditis |
5 |
bacterial infections - diagnosis - microbiology |
5 |
bacterial infections - microbiology |
5 |
bacterial typing techniques - methods |
5 |
bacteriuria |
5 |
bats |
5 |
beta-lactamases - analysis |
5 |
beta-lactamases - biosynthesis - genetics |
5 |
beta-lactamases - chemistry - genetics |
5 |
birds |
5 |
bk virus - genetics - immunology - pathogenicity |
5 |
bk virus - isolation & purification - physiology |
5 |
bk virus nephropathy |
5 |
blood platelets - microbiology |
5 |
bone marrow - pathology |
5 |
bone marrow transplant |
5 |
booster |
5 |
broad-spectrum antivirals |
5 |
calibration |
5 |
caliciviridae infections - epidemiology - prevention and control - transmission |
5 |
california sea lions |
5 |
campylobacter fetus - classification - genetics - growth & development - isolation & purification |
5 |
campylobacter infections - microbiology |
5 |
cardio-renal metabolic syndrome |
5 |
catalase |
5 |
catheterization - adverse effects |
5 |
ccl22 |
5 |
cell movement - immunology |
5 |
cell nucleus - genetics |
5 |
characterization |
5 |
chemokine cxcl13 - biosynthesis - immunology |
5 |
chinese horseshoe bats |
5 |
cholecystitis - microbiology |
5 |
chromobacterium violaceum |
5 |
ciprofloxacin - pharmacology - therapeutic use |
5 |
ciprofloxacin - therapeutic use |
5 |
circrna |
5 |
clostridium difficile - classification - genetics - isolation and purification |
5 |
cmv |
5 |
cofactors |
5 |
communicable diseases - classification |
5 |
communicable diseases, emerging |
5 |
communicable diseases, emerging - microbiology |
5 |
community-acquired infections - microbiology |
5 |
competing endogenous rna |
5 |
complication |
5 |
construction strategies |
5 |
contact examination |
5 |
coronaviridae - chemistry - classification - genetics - isolation and purification |
5 |
covid-19 severity |
5 |
coxiella burnetii |
5 |
cross infection - diagnosis - epidemiology - virology |
5 |
cross infection - epidemiology - prevention and control - transmission |
5 |
cross infection - microbiology - prevention and control - transmission |
5 |
cross infection - prevention and control - transmission - virology |
5 |
cryptococcosis - diagnosis - etiology |
5 |
cytomegalovirus - drug effects - genetics - isolation & purification |
5 |
cytomegalovirus - genetics - immunology - pathogenicity |
5 |
cytomegalovirus infections - immunology - virology |
5 |
databases, nucleic acid |
5 |
deltacoronavirus |
5 |
diagnostic errors |
5 |
discitis - diagnosis - drug therapy |
5 |
disease outbreaks - prevention and control - statistics and numerical data |
5 |
disease susceptibility |
5 |
disinfection |
5 |
dna, bacterial |
5 |
dna, complementary - analysis |
5 |
dna, mitochondrial - genetics |
5 |
dna, protozoan - blood - genetics |
5 |
dna, ribosomal |
5 |
dna, ribosomal - analysis - genetics |
5 |
dna, ribosomal - genetics |
5 |
dna, viral - analysis - genetics |
5 |
dna, viral - blood - drug effects |
5 |
dog diseases - microbiology |
5 |
drug dosage form comparison |
5 |
drug dose comparison |
5 |
drug resistance, multiple, bacterial - genetics |
5 |
drug resistance, viral - genetics |
5 |
electrophoresis, gel, pulsed-field - methods |
5 |
emergency service, hospital |
5 |
emerging infectious disease |
5 |
empyema, pleural - microbiology |
5 |
encephalities |
5 |
endocarditis, bacterial |
5 |
endocarditis, bacterial - microbiology |
5 |
enterocolitis, pseudomembranous - epidemiology - microbiology |
5 |
enterovirus - classification - genetics - isolation and purification |
5 |
erythromycin - pharmacology |
5 |
escherichia coli - drug effects - genetics - metabolism |
5 |
escherichia coli - genetics - metabolism |
5 |
expression |
5 |
falcon |
5 |
famotidine - pharmacology |
5 |
fecal-to-oral transmission |
5 |
fever - etiology - therapy |
5 |
fever - microbiology |
5 |
fluoroquinolones |
5 |
food contamination |
5 |
fresh water - microbiology |
5 |
fungi |
5 |
fusarium |
5 |
gene components - genetics |
5 |
gene expression profiling |
5 |
gene expression regulation |
5 |
genes - genetics |
5 |
genes, fungal |
5 |
genetic variation - genetics |
5 |
genogroup |
5 |
genogroup i |
5 |
gentian violet |
5 |
glucose homeostasis |
5 |
glutathione transferase - genetics - metabolism |
5 |
gout - microbiology |
5 |
graft vs host disease |
5 |
gram-negative bacterial infections - microbiology |
5 |
gram-positive bacteria - classification - genetics |
5 |
gram-positive bacterial infections - diagnosis - drug therapy |
5 |
gram-positive cocci |
5 |
green fluorescent proteins - genetics - metabolism |
5 |
guinea pigs |
5 |
h1n1 virus |
5 |
h5n1 influenza virus |
5 |
h9n2 |
5 |
haemophilus - classification - genetics - isolation & purification |
5 |
haplorhini |
5 |
haplotypes |
5 |
hepatitis b, chronic - genetics - virology |
5 |
hepatitis c |
5 |
herpes simplex virus 2 |
5 |
herpesviridae |
5 |
herpesviridae infections - blood - drug therapy - etiology |
5 |
herpesvirus 6, human - drug effects - genetics - isolation & purification |
5 |
herpesvirus 7, human - drug effects - genetics - isolation & purification |
5 |
histamine h2 antagonists - pharmacology |
5 |
hiv-1 |
5 |
hku2 |
5 |
hnpcs |
5 |
horses |
5 |
hot temperature |
5 |
houbara bustard |
5 |
human alphaherpesvirus 1 |
5 |
human coronavirus |
5 |
human coronaviruses |
5 |
human parechovirus |
5 |
hybrid immunity |
5 |
identification |
5 |
ifngr1 |
5 |
il-17 |
5 |
immunization, passive |
5 |
immunoglobulins |
5 |
immunological comparison |
5 |
immunosuppressive agents - administration & dosage |
5 |
implant |
5 |
inducible |
5 |
infection control bundle |
5 |
influenza a virus - genetics - isolation & purification |
5 |
influenza a virus, h1n1 subtype - classification - genetics - isolation & purification |
5 |
influenza a virus, h1n1 subtype - genetics - isolation & purification |
5 |
influenza a virus, h2n2 subtype - classification - genetics - isolation & purification |
5 |
influenza a virus, h3n2 subtype - classification - genetics - isolation & purification |
5 |
influenza a virus, h3n2 subtype - genetics - isolation and purification |
5 |
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
5 |
influenza a virus, h7n9 subtype - genetics - isolation and purification |
5 |
influenza vaccines |
5 |
influenza, human - prevention and control - transmission - virology |
5 |
injections, intravenous |
5 |
inpatients |
5 |
interleukin-17 - deficiency - genetics - immunology |
5 |
interspecies jumping |
5 |
invasive infections |
5 |
isolation |
5 |
isoniazid - pharmacology |
5 |
its sequencing |
5 |
keratitis - microbiology |
5 |
kidney calculi - etiology - urine |
5 |
kidney failure, chronic - surgery |
5 |
kytococcus schroeteri |
5 |
lactococcus - classification - genetics - pathogenicity |
5 |
leukemia |
5 |
leukocytes, mononuclear - virology |
5 |
library |
5 |
likelihood functions |
5 |
lipid-protein interaction |
5 |
lipocalin-2 |
5 |
live oral vaccine |
5 |
liver - pathology - virology |
5 |
logistic models |
5 |
longitudinal studies |
5 |
luciferases - genetics - metabolism |
5 |
luminescent measurements |
5 |
luminex nxtag |
5 |
lung infection |
5 |
lymphatic diseases - diagnosis - etiology |
5 |
lymphocyte count |
5 |
lymphoma - diagnosis |
5 |
magnetic resonance imaging |
5 |
malaria - diagnosis - parasitology |
5 |
malaria, falciparum - blood - diagnosis |
5 |
mammals |
5 |
medical sciences biology |
5 |
metabolic profiling |
5 |
mice, knockout |
5 |
mice, transgenic |
5 |
microarray analysis - methods |
5 |
mirna |
5 |
mitochondria |
5 |
mitochondria - genetics |
5 |
mitochondrial genome |
5 |
molecular |
5 |
molecular diagnostic techniques - economics - methods |
5 |
mrna |
5 |
mucorales |
5 |
multiplex real time polymerase chain reaction |
5 |
mycobacterium infections - etiology - microbiology |
5 |
mycobacterium tuberculosis - drug effects - genetics - isolation & purification |
5 |
myeloperoxidase |
5 |
myelosuppression |
5 |
nasopharyngeal specimen |
5 |
neisseria gonorrhoeae |
5 |
neisseria meningitidis |
5 |
neisseriaceae - classification - genetics - isolation & purification |
5 |
neisseriaceae - classification - genetics - isolation and purification |
5 |
neisseriaceae - genetics - isolation & purification - metabolism |
5 |
neisseriaceae infections - microbiology |
5 |
neisseriaceae infections - microbiology - transmission |
5 |
nephritis, interstitial - diagnosis - virology |
5 |
neutralizing antibody spike protein receptor binding domain |
5 |
nmr-based urinalysis |
5 |
nontuberculous mycobacterium |
5 |
norovirus - genetics - isolation and purification |
5 |
noroviruses |
5 |
north america |
5 |
nose - microbiology |
5 |
nosocomial infection |
5 |
novel virus |
5 |
ns1 |
5 |
ns5 protein |
5 |
nuclear magnetic resonance |
5 |
odds ratio |
5 |
opportunistic infections - immunology - virology |
5 |
oral dna vaccination |
5 |
origin |
5 |
orthomyxoviridae infections - diagnosis - virology |
5 |
orthomyxoviridae infections - immunology - mortality - pathology - virology |
5 |
oseltamivir - pharmacology |
5 |
osteomyelitis |
5 |
osteomyelitis - microbiology |
5 |
pathology |
5 |
patient isolation - methods |
5 |
pelvic actinomycosis |
5 |
pelvic inflammatory disease - microbiology |
5 |
penicillium - classification - genetics |
5 |
phaeoacremonium parasiticum |
5 |
phenazines |
5 |
picobirnaviruses |
5 |
picornaviridae infections - veterinary - virology |
5 |
plasmodium falciparum - genetics - isolation & purification |
5 |
plasmodium malariae - genetics - isolation and purification |
5 |
point-of-care systems |
5 |
polyamination |
5 |
polymerase chain reaction - economics - methods - standards |
5 |
polyomavirus infections - diagnosis - etiology |
5 |
polyomavirus infections - prevention & control - virology |
5 |
polysaccharides, bacterial - biosynthesis |
5 |
population susceptibility |
5 |
prisma |
5 |
promoter activity |
5 |
prosthesis-related infections - microbiology |
5 |
protein stability |
5 |
proteobacteria - enzymology - genetics |
5 |
pulmonology |
5 |
pyoderma - microbiology - veterinary |
5 |
pyrimidine synthesis inhibitor |
5 |
quantitative rt-pcr |
5 |
rabbits - virology |
5 |
rapid molecular test |
5 |
receptor |
5 |
receptor, interferon alpha-beta - biosynthesis - genetics |
5 |
receptors, cxcr5 - biosynthesis - immunology |
5 |
receptors, interferon - genetics |
5 |
recombinant |
5 |
recombinant proteins - immunology |
5 |
reference standards |
5 |
referral and consultation |
5 |
renal abscess |
5 |
respiratory tract infections - etiology - microbiology |
5 |
reverse transcriptase polymerase chain reaction - economics - methods |
5 |
review |
5 |
ribavirin - therapeutic use |
5 |
ribotype 027 |
5 |
ribotyping |
5 |
rna virus |
5 |
rna, bacterial - analysis |
5 |
rna, ribosomal, 16s - analysis |
5 |
rna, ribosomal, 16s - analysis - genetics |
5 |
rna, ribosomal, 16s - chemistry - genetics |
5 |
rna, ribosomal, 18s - genetics |
5 |
rna, transfer - genetics |
5 |
rna, viral - analysis - genetics - isolation & purification |
5 |
rubulavirus infections - diagnosis - epidemiology - virology |
5 |
rubulavirus infections - epidemiology - virology |
5 |
s. aureus |
5 |
salivirus |
5 |
salmonella typhimurium |
5 |
salmonella typhimurium - genetics |
5 |
sars virus - genetics - growth & development - isolation & purification |
5 |
sars virus - metabolism |
5 |
sars-cov-2 n501y variant |
5 |
sea lion |
5 |
selection |
5 |
sequence analysis, dna - standards |
5 |
sequence analysis, rna |
5 |
sequence analysis, rna - methods |
5 |
seroepidemiological study |
5 |
severe acute respiratory syndrome - blood - mortality - virology |
5 |
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control - transmission - virology |
5 |
shuttle vector |
5 |
smell training |
5 |
soluble and insoluble antigens |
5 |
specimen handling - methods |
5 |
spectrometry, mass, matrix-assisted laser desorption-ionization |
5 |
spores, bacterial |
5 |
staphylococcal infections - microbiology - prevention and control - transmission |
5 |
staphylococcal skin infections - microbiology - veterinary |
5 |
staphylococcus - classification - genetics |
5 |
staphylococcus - genetics |
5 |
staphylococcus aureus - classification - drug effects - isolation & purification |
5 |
stat1 |
5 |
stat2 |
5 |
streptococcal infections - diagnosis - microbiology |
5 |
streptococcal infections - epidemiology - microbiology |
5 |
streptococcus - classification - isolation & purification |
5 |
streptococcus - classification - isolation & purification - pathogenicity - physiology |
5 |
streptococcus iniae |
5 |
t cell |
5 |
tomography, x-ray computed |
5 |
transformation, bacterial |
5 |
transformation, genetic |
5 |
transplantation, homologous |
5 |
triazines - analysis - chemistry - urine |
5 |
trimethylamine |
5 |
tuberculosis, pulmonary - diagnosis - drug therapy - microbiology |
5 |
tumor virus infections - diagnosis - etiology |
5 |
tumor virus infections - prevention & control - virology |
5 |
type ii interferon |
5 |
urinary tract infection |
5 |
viral envelope proteins - genetics |
5 |
viral envelope proteins - immunology |
5 |
viral persistence |
5 |
viridans streptococci - classification - cytology - immunology - physiology |
5 |
voc |
5 |
water microbiology |
5 |
weight loss |
5 |
wireless sensor networks |
5 |
x-ray crystallography |
5 |
xpert xpress flu/rsv |
5 |
yeasts - genetics |
5 |
β-tubulin gene sequencing |
5 |
16s rrna, groel |
4 |
abscess - diagnosis - microbiology |
4 |
abscess - microbiology |
4 |
acinetobacter - genetics |
4 |
acinetobacter - isolation & purification - metabolism |
4 |
acinetobacter-infections-epidemiology |
4 |
acinetobacter-isolation-and-purification |
4 |
actinobacteria - classification - genetics - isolation & purification - physiology |
4 |
acupuncture |
4 |
acute cholecystitis |
4 |
acyl-coa dehydrogenase - genetics - metabolism |
4 |
adaptor proteins, signal transducing - metabolism |
4 |
adenocarcinoma - complications - diagnosis - therapy |
4 |
adenolymphoma - complications - microbiology |
4 |
adenoviridae - genetics - isolation & purification |
4 |
adenoviridae - isolation & purification |
4 |
adenoviridae - physiology |
4 |
adenoviridae infections - etiology - pathology |
4 |
adenovirus infections, human - diagnosis - virology |
4 |
adenoviruses, human - genetics - isolation and purification |
4 |
adenoviruses, human - isolation and purification |
4 |
adhesion factor |
4 |
adoptive immune transfer |
4 |
adsa |
4 |
aerobiosis |
4 |
agar gel electrophoresis |
4 |
aids-related opportunistic infections - diagnosis |
4 |
alemtuzumab |
4 |
algorithms |
4 |
alkanindiges hongkongensis |
4 |
ampicillin - therapeutic use |
4 |
anaerospora hongkongensis |
4 |
anaplasma platys |
4 |
ancylostoma duodenale |
4 |
animal rna viruses |
4 |
anisakis simplex |
4 |
anti-bacterial agents - administration & dosage - pharmacology - toxicity |
4 |
anti-bacterial agents - administration & dosage - therapeutic use |
4 |
anti-infective agents - pharmacology |
4 |
anti-infective agents - therapeutic use |
4 |
antibiotics |
4 |
antibodies |
4 |
antibodies, bacterial - blood - immunology |
4 |
antibodies, fungal - blood |
4 |
antibodies, fungal - blood - diagnostic use - immunology |
4 |
antibodies, fungal - immunology |
4 |
antibodies, monoclonal - administration & dosage - adverse effects |
4 |
antibodies, monoclonal, humanized |
4 |
antibodies, neoplasm - administration & dosage - adverse effects |
4 |
antibodies, viral - analysis |
4 |
antigen detection |
4 |
antigens - genetics - metabolism |
4 |
antigens, bacterial |
4 |
antigens, bacterial - genetics - immunology |
4 |
antigens, fungal - analysis - blood - immunology |
4 |
antigens, fungal - genetics |
4 |
antigens, fungal - genetics - immunology |
4 |
antimicrobial resistance |
4 |
antineoplastic agents - administration & dosage - adverse effects |
4 |
antineoplastic agents - adverse effects |
4 |
antitubercular agents - administration & dosage |
4 |
antiviral therapy |
4 |
anura - microbiology |
4 |
aortic aneurysm, abdominal - complications - diagnosis - pathology - therapy |
4 |
appendectomy |
4 |
appendicitis - microbiology - pathology |
4 |
appendix perforation |
4 |
arcobacter - classification - isolation & purification |
4 |
arthritis, reactive - complications - microbiology |
4 |
ascariasis - diagnosis |
4 |
ascaris lumbricoides |
4 |
ascomycota - genetics - isolation & purification |
4 |
asian continental ancestry group |
4 |
aspergillosis - diagnosis - microbiology |
4 |
aspergillus flavus - genetics - immunology - metabolism |
4 |
aspergillus fumigatus - chemistry - immunology - isolation & purification |
4 |
aspergillus fumigatus - genetics - immunology |
4 |
astrocytes - virology |
4 |
autoimmune diseases - blood - complications - drug therapy - virology |
4 |
avian influenza a virus |
4 |
azithromycin - therapeutic use |
4 |
babesia |
4 |
bacillaceae - genetics - isolation & purification - ultrastructure |
4 |
bacteremia - diagnosis - drug therapy - microbiology |
4 |
bacteremia - drug therapy - etiology - mortality |
4 |
bacteremia - drug therapy - microbiology |
4 |
bacteremia - epidemiology |
4 |
bacteremia-epidemiology |
4 |
bacterial infections - diagnosis - drug therapy - epidemiology |
4 |
bacterial outer membrane proteins - genetics |
4 |
bacterial proteins - genetics - metabolism |
4 |
bacterium culture |
4 |
bactrian came |
4 |
beta-lactamases - biosynthesis |
4 |
beta-lactamases - genetics - metabolism |
4 |
biliary tract diseases |
4 |
binding sites - genetics |
4 |
bk virus - genetics - isolation & purification |
4 |
bk virus - physiology |
4 |
blood sampling |
4 |
bone marrow transplantation - adverse effects - immunology |
4 |
bone marrow transplantation - adverse effects - methods - pathology |
4 |
bone marrow transplantation -immunology |
4 |
brain diseases - microbiology |
4 |
broad-spectrum antiviral drugs |
4 |
bronchoalveolar lavage fluid - microbiology |
4 |
burkholderia - classification - genetics |
4 |
burkholderia pseudomallei - classification - genetics - immunology |
4 |
burkholderia pseudomallei - genetics - isolation & purification |
4 |
busulfan - adverse effects - therapeutic use |
4 |
caliciviridae infections - genetics |
4 |
caliciviridae infections - veterinary - virology |
4 |
capnocytophaga - isolation and purification |
4 |
capping phenomenon |
4 |
carbapenem-resistant acinetobacter species |
4 |
carbapenemase-producing enterobacteriaceae |
4 |
cardiac complications |
4 |
carps - microbiology |
4 |
carrier proteins - analysis |
4 |
catalase - analysis |
4 |
catheterization, central venous - adverse effects |
4 |
catheters, indwelling - adverse effects |
4 |
ccaat-enhancer-binding proteins - metabolism |
4 |
cd4-cd8 ratio |
4 |
cd8-positive t-lymphocytes - immunology - virology |
4 |
cecal diseases - diagnosis - parasitology |
4 |
cefoperazone - pharmacology |
4 |
cefotaxime/adverse effects |
4 |
cell death |
4 |
cell wall - chemistry |
4 |
cell wall - chemistry - immunology |
4 |
cells, cultured |
4 |
cellular immune response |
4 |
central venous catheter |
4 |
cephalosporin resistance |
4 |
cercopithecus aethiops |
4 |
cerebrospinal fluid |
4 |
chaperonin 60 - analysis |
4 |
chaperonin 60 - chemistry |
4 |
child day care centers |
4 |
chinese tiger frog |
4 |
cholangitis - microbiology |
4 |
chronic hbv infection |
4 |
clade a |
4 |
clarithromycin - administration & dosage - pharmacology - toxicity |
4 |
clarithromycin - pharmacology |
4 |
class iii pi3-k |
4 |
cleavage of s protein |
4 |
clinical |
4 |
clinical laboratory |
4 |
cloaca - microbiology |
4 |
clonorchiasis |
4 |
codon - genetics |
4 |
codon usage |
4 |
colonic carcinoma |
4 |
colonic neoplasms - complications - diagnosis - therapy |
4 |
colonization |
4 |
communicable disease control |
4 |
communicable diseases public health and safety |
4 |
communicable diseases, emerging - epidemiology - virology |
4 |
community-acquired gastroenteritis |
4 |
community-acquired infections - epidemiology - microbiology |
4 |
community-acquired infections - epidemiology - microbiology - physiopathology |
4 |
community-acquired infections - virology |
4 |
complications |
4 |
computational biology |
4 |
conjunctivitis |
4 |
conjunctivitis - virology |
4 |
consensus sequence |
4 |
conserved sequence |
4 |
consumer product safety |
4 |
contact tracing |
4 |
coronavirus - genetics |
4 |
coronavirus infections - epidemiology - veterinary - virology |
4 |
coronavirus infections - epidemiology - virology |
4 |
cpg island |
4 |
cross infection - epidemiology - microbiology |
4 |
cryptococcosis - blood - chemically induced |
4 |
culture |
4 |
culture media, conditioned - chemistry |
4 |
cyanuric acid |
4 |
cysteine endopeptidases - metabolism |
4 |
cystitis - diagnosis - etiology - virology |
4 |
cystitis - etiology - pathology - urine - virology |
4 |
cytomegalovirus - genetics - isolation & purification |
4 |
cytomegalovirus infections - blood - chemically induced - prevention & control |
4 |
cytomegalovirus infections - blood - diagnosis - epidemiology |
4 |
cytomegalovirus reactivation |
4 |
cytotoxic t cell |
4 |
cytotoxicity, immunologic |
4 |
dependovirus |
4 |
dermatomycoses - microbiology |
4 |
diagnostic test evaluation |
4 |
diarrhea - drug therapy - epidemiology - microbiology |
4 |
differential gene expression |
4 |
dimorphic |
4 |
dirofilaria immitis |
4 |
disease models, animal |
4 |
disease surveillance |
4 |
distribution |
4 |
dna base composition |
4 |
dna gyrase - chemistry - genetics |
4 |
dna helicases - genetics |
4 |
dna primers - genetics |
4 |
dna probes - genetics |
4 |
dna, fungal - analysis |
4 |
dna, recombinant - administration & dosage |
4 |
dna, ribosomal - chemistry |
4 |
dna, viral - analysis |
4 |
dna, viral - genetics - isolation & purification |
4 |
dna-binding proteins - genetics |
4 |
dna-binding proteins - genetics - metabolism |
4 |
dog |
4 |
dromedary camels |
4 |
drug repurposing |
4 |
drug resistance, multiple, bacterial |
4 |
drug therapy |
4 |
ecosystem |
4 |
ehrlichia |
4 |
electron transport complex iv - analysis |
4 |
eliminated non-coding orfs |
4 |
endemicity |
4 |
endocarditis |
4 |
endocarditis, bacterial - complications - diagnosis - therapy |
4 |
endocarditis, bacterial - diagnosis - microbiology |
4 |
endoplasmic reticulum - metabolism |
4 |
enterococcus faecium - isolation & purification |
4 |
epithelial cells - metabolism |
4 |
epitope |
4 |
epstein-barr virus |
4 |
esbl-producing enterobacterales |
4 |
escherichia coli - drug effects - enzymology - isolation & purification |
4 |
escherichia coli - genetics |
4 |
escherichia coli infections - microbiology |
4 |
evolution |
4 |
ex vivo human lung tissues |
4 |
extended-spectrum β-lactamases |
4 |
extracellular |
4 |
factor xa - metabolism |
4 |
fade28 |
4 |
fatty acids - analysis |
4 |
feces |
4 |
fishes |
4 |
fluoroquinolones - pharmacology |
4 |
foot and mouth disease |
4 |
freshwater fish |
4 |
fungal proteins - genetics |
4 |
fungal proteins - genetics - immunology - isolation & purification |
4 |
fungemia - blood - chemically induced |
4 |
fungemia - etiology - mortality |
4 |
fungi - isolation and purification |
4 |
fungus |
4 |
gallstones - complications - diagnosis - microbiology |
4 |
gastroenteritis - drug therapy - epidemiology - microbiology |
4 |
gastroenteritis - virology |
4 |
gastrointestinal colonization |
4 |
gene amplification |
4 |
gene expression |
4 |
gene expression regulation - immunology |
4 |
gene expression regulation, viral |
4 |
gene expression regulation, viral - immunology |
4 |
gene therapy |
4 |
genes,-rrna |
4 |
genomic rearrangement |
4 |
genotype 6 |
4 |
gills - microbiology |
4 |
glucose - metabolism |
4 |
glutamine |
4 |
glyceraldehyde-3-phosphate dehydrogenase |
4 |
graft vs host disease - complications - immunology |
4 |
gram-negative bacterial infections - diagnosis |
4 |
gram-negative bacterial infections - diagnosis - epidemiology |
4 |
gram-negative bacterial infections - drug therapy - etiology |
4 |
gram-negative bacterial infections - epidemiology - microbiology |
4 |
gram-positive bacteria - classification - isolation & purification |
4 |
gram-positive bacterial infections - diagnosis - drug therapy - microbiology |
4 |
gram-positive bacterial infections - diagnosis - microbiology |
4 |
gram-positive bacterial infections - microbiology - veterinary |
4 |
h10n8 |
4 |
h5n1 subtype |
4 |
haemophilus infections |
4 |
hand |
4 |
hand foot and mouth disease |
4 |
hbv |
4 |
heat-shock proteins - metabolism |
4 |
hematopoietic stem cell transplantation - adverse effects - methods |
4 |
hematopoietic stem cells - immunology |
4 |
hematuria - diagnosis - etiology - virology |
4 |
hemorrhage - etiology - pathology - surgery - virology |
4 |
hepatitis b antibodies - biosynthesis |
4 |
hepatitis b antibodies - biosynthesis - blood - immunology |
4 |
hepatitis b antigens - metabolism |
4 |
hepatitis b surface antigens - biosynthesis |
4 |
hepatitis b surface antigens - genetics - immunology |
4 |
hepatitis b vaccines - administration & dosage |
4 |
hepatitis b vaccines - administration & dosage - immunology |
4 |
hepatitis b virus - immunology - metabolism |
4 |
herpes zoster |
4 |
herpes zoster - epidemiology - etiology - pathology |
4 |
herpesvirus 4, human - immunology |
4 |
hexosyltransferases |
4 |
histidine |
4 |
histopathology |
4 |
hiv core protein p24 - immunology |
4 |
hiv infections - prevention and control |
4 |
hiv-1 - immunology |
4 |
host susceptibilities |
4 |
hrv-c |
4 |
hsp70 heat-shock proteins - metabolism |
4 |
human hepegivirus 1 |
4 |
human herpesvirus 6 |
4 |
human infection |
4 |
humoral immune response |
4 |
hydrodynamic transfection |
4 |
hypervirulent strain |
4 |
ifn |
4 |
ifnar1 promoter polymorphisms |
4 |
immune impairment |
4 |
immunocompromised host - drug effects |
4 |
immunodeficiency |
4 |
immunogenic protein |
4 |
immunoglobulin a - immunology |
4 |
immunoglobulin g - biosynthesis - blood - immunology |
4 |
immunologic techniques |
4 |
immunosuppressive agents - adverse effects |
4 |
immunosuppressive agents - adverse effects - therapeutic use |
4 |
immunotherapy |
4 |
inactivated influenza |
4 |
inbred mouse lines |
4 |
infection control - standards |
4 |
infectious diarrhoea |
4 |
influenza (h7n9) virus |
4 |
influenza a virus - classification - genetics - pathogenicity |
4 |
influenza a virus - classification - isolation and purification |
4 |
influenza a virus, h1n1 subtype - drug effects |
4 |
influenza a virus, h1n1 subtype - genetics - physiology |
4 |
influenza a virus, h1n1 subtype - immunology - isolation and purification |
4 |
influenza a virus, h1n1 subtype - immunology - isolation and purification - pathogenicity |
4 |
influenza a virus, h5n1 subtype - genetics - immunology - isolation & purification |
4 |
influenza a virus, h5n1 subtype - genetics - physiology |
4 |
influenza a virus, h5n1 subtype - isolation and purification |
4 |
influenza a virus, h7n9 subtype - immunology - isolation and purification |
4 |
influenza a virus, h7n9 subtype - isolation and purification |
4 |
influenza in birds - epidemiology - virology |
4 |
influenza in birds - transmission |
4 |
influenza, human - blood - pathology - virology |
4 |
influenza, human - epidemiology - prevention and control - transmission - virology |
4 |
influenza, human - mortality - therapy - virology |
4 |
influenza, human - pathology - physiopathology - virology |
4 |
inhibition of hbv transgene |
4 |
inhibition of scov reproduction |
4 |
innate immune response |
4 |
interferon type i - genetics - immunology |
4 |
interferon-alpha - metabolism |
4 |
interferon-gamma |
4 |
interferon-gamma - secretion |
4 |
interferon-α1 |
4 |
interleukin-4 - secretion |
4 |
intussusception - diagnosis - parasitology |
4 |
jaundice, obstructive - complications - diagnosis - microbiology |
4 |
kidney - virology |
4 |
kidney calculi - epidemiology - metabolism - urine |
4 |
l336m |
4 |
lactobacillus |
4 |
lactobacillus rhamnosus |
4 |
lactobacillus rhamnosus - genetics - isolation & purification |
4 |
lhybrid camel |
4 |
lineage |
4 |
linkage disequilibrium |
4 |
liver - pathology |
4 |
liver - radiography |
4 |
liver abscess |
4 |
liver abscess - complications - diagnosis - microbiology |
4 |
liver cirrhosis, alcoholic - complications |
4 |
liver failure - complications |
4 |
liver transplantation |
4 |
lung - microbiology - pathology - radiography |
4 |
lung diseases, parasitic - diagnosis |
4 |
lymphocyte activation |
4 |
lymphoma - blood - complications - drug therapy - virology |
4 |
lymphoma, follicular - drug therapy - immunology |
4 |
lymphoma, non-hodgkin - drug therapy - immunology |
4 |
macaca mulatta |
4 |
macrolides - therapeutic use |
4 |
macrophage |
4 |
macrophages - metabolism - virology |
4 |
macrophages, peritoneal - immunology - transplantation - virology |
4 |
mating type genes |
4 |
maxillary sinusitis - complications - microbiology |
4 |
mdscs |
4 |
melamine |
4 |
melamine-associated renal stone disease |
4 |
melioidosis - diagnosis - genetics - microbiology |
4 |
membrane glycoproteins - analysis - blood - immunology |
4 |
membrane glycoproteins - chemistry |
4 |
membrane glycoproteins - chemistry - genetics - immunology |
4 |
membrane proteins - metabolism |
4 |
memory cd8 t cell response |
4 |
metagenomic analysis |
4 |
microscopy |
4 |
middle east respiratory syndrome coronavirus (mers-cov) |
4 |
mirizzi syndrome |
4 |
mirna-seq |
4 |
molecular biology |
4 |
molecular chaperones - metabolism |
4 |
molecular sequence numbers |
4 |
monitoring, physiologic - methods |
4 |
monkeys |
4 |
monocytes |
4 |
moraxellaceae - classification - cytology - isolation & purification - physiology |
4 |
moraxellaceae infections - complications - microbiology |
4 |
mouth mucosa |
4 |
movement |
4 |
mrna vaccine |
4 |
mrna-seq |
4 |
mucorales - isolation & purification - physiology |
4 |
mucormycosis - microbiology |
4 |
multidrug-resistant organisms |
4 |
multiple myeloma - complications - diagnosis - pathology - therapy |
4 |
multiple myeloma - therapy |
4 |
multiple organ failure - etiology |
4 |
multivalent vaccine |
4 |
muramoylpentapeptide carboxypeptidase - analysis |
4 |
mycobacteriosis |
4 |
mycobacterium tuberculosis - classification - genetics - metabolism - pathogenicity |
4 |
mycobacterium tuberculosis - drug effects - genetics |
4 |
mycobacterium tuberculosis - genetics |
4 |
mycoplasma pneumoniae - metabolism |
4 |
mycoses - complications - microbiology |
4 |
mycoses - epidemiology - microbiology |
4 |
mycoses - etiology - mortality |
4 |
mycoses - microbiology |
4 |
mycosis |
4 |
nasal colonisation |
4 |
nasopharyngeal carcinoma |
4 |
nasopharyngeal neoplasms - complications - therapy |
4 |
nasopharyngeal neoplasms - immunology - therapy - virology |
4 |
nasopharynx - microbiology |
4 |
neisseriaceae - classification - drug effects - isolation & purification |
4 |
neisseriaceae - classification - genetics - isolation & purification - pathogenicity |
4 |
neisseriaceae - classification - genetics - isolation & purification - ultrastructure |
4 |
neisseriaceae - drug effects - growth & development - isolation & purification |
4 |
neisseriaceae - growth & development - isolation & purification |
4 |
neisseriaceae - isolation and purification |
4 |
neisseriaceae infections - epidemiology - microbiology |
4 |
neuraminidase - antagonists & inhibitors - genetics |
4 |
neutropenia - complications |
4 |
neutropenia - microbiology |
4 |
new |
4 |
newly assigned functions |
4 |
newly found genes |
4 |
norovirus - classification - genetics - isolation and purification |
4 |
norovirus - genetics |
4 |
nose diseases - microbiology |
4 |
nosocomial |
4 |
novel bacterium |
4 |
novel coronaviruses |
4 |
novel picobirnaviruses |
4 |
nucleocapsid proteins - genetics - metabolism |
4 |
occupational exposure |
4 |
omicron breakthrough infection |
4 |
opportunistic infections - diagnosis - immunology - microbiology |
4 |
oral cavity |
4 |
oral mucositis |
4 |
orf1ab |
4 |
orf8 |
4 |
organ specificity |
4 |
orthomyxoviridae infections - virology |
4 |
oxidation-reduction |
4 |
pa |
4 |
palliative care - methods |
4 |
pancytopenia - blood - complications - drug therapy - virology |
4 |
papillomavirus infections - diagnosis - etiology - virology |
4 |
papillomavirus infections - etiology - pathology |
4 |
paracetamol |
4 |
parotid abscess |
4 |
parotid diseases - microbiology |
4 |
parotid gland - microbiology |
4 |
parotid neoplasms - complications - microbiology |
4 |
partitivirus |
4 |
patients |
4 |
penicillin-binding proteins |
4 |
penicillins - therapeutic use |
4 |
penicillium - classification - genetics - physiology |
4 |
penicillium - classification - immunology - isolation & purification |
4 |
penicillium - metabolism |
4 |
peptide elongation factor 1 - genetics |
4 |
peptides - chemistry - genetics |
4 |
peptidyl transferases |
4 |
peptococcaceae - classification - cytology - isolation & purification - physiology |
4 |
peripheral blood monocyte |
4 |
peritoneal dialysis, continuous ambulatory - adverse effects |
4 |
peritonitis - classification - etiology - microbiology |
4 |
peritonitis - drug therapy - etiology - microbiology |
4 |
peritonitis - microbiology |
4 |
persistent virus infection |
4 |
pge2 |
4 |
phosphoric monoester hydrolases - genetics |
4 |
picobirnavirus - genetics - isolation and purification |
4 |
picornavirus |
4 |
plasmid |
4 |
plasmid profile |
4 |
plasmids - metabolism |
4 |
plesiomonas - classification - isolation & purification |
4 |
plesiomonas shigelloides |
4 |
pneumococcal infections |
4 |
pneumococcal infections - complications - diagnosis - pathology - therapy |
4 |
pneumococcal infections/drug therapy |
4 |
pneumonia - complications - microbiology |
4 |
pneumonia - drug therapy - radiography |
4 |
point-of care |
4 |
polyoma bk virus |
4 |
polyomavirus infections - complications - diagnosis |
4 |
polyphyletic |
4 |
poultry workers |
4 |
practice guidelines as topic |
4 |
prevention of xbb.1.5 transmission |
4 |
proctitis - complications |
4 |
programmed cell death 1 receptor - immunology |
4 |
protease factor xa |
4 |
protease inhibitor |
4 |
protein binding |
4 |
protein conformation |
4 |
protein denaturation |
4 |
proteinase k |
4 |
proteomics |
4 |
proteus mirabilis - classification - drug effects - enzymology |
4 |
pseudobacteremia |
4 |
pulmonary delivery |
4 |
pulmonary eosinophilia - diagnosis - parasitology |
4 |
q fever |
4 |
q fever - diagnosis - epidemiology |
4 |
re-annotation |
4 |
reactive dermatosis |
4 |
realstar® hhv-6 pcr kit |
4 |
reassortant viruses - immunology - isolation and purification |
4 |
recombinant proteins - immunology - isolation & purification |
4 |
recombinases - genetics |
4 |
recombineering salmonella vaccine |
4 |
rectal neoplasms - complications |
4 |
rectum - microbiology |
4 |
replication origin - genetics |
4 |
resequencing microarray |
4 |
reservoir |
4 |
respiratory tracts |
4 |
reverse transcriptase polymerase chain reaction - methods - statistics & numerical |
4 |
rna virus infections - epidemiology - transmission - virology |
4 |
rna virus infections - veterinary - virology |
4 |
rna viruses - genetics - growth & development |
4 |
rna, small interfering |
4 |
rna, small interfering - genetics |
4 |
rna,-bacterial-genetics |
4 |
rna,-ribosomal,-16s-analysis |
4 |
rodentia - microbiology |
4 |
saliva - microbiology |
4 |
salmonella typhi - classification - genetics - isolation & purification |
4 |
salmonella typhi - genetics - metabolism |
4 |
sampling studies |
4 |
sars virus - enzymology - genetics - pathogenicity - physiology |
4 |
sars virus - immunology - isolation & purification |
4 |
sars-associated coronavirus |
4 |
sea lions - virology |
4 |
seafood - microbiology |
4 |
seasonal |
4 |
sedimentibacter hongkongensis sp. nov. |
4 |
sequence |
4 |
serological surveillance |
4 |
severe acute respiratory syndrome - diagnosis - epidemiology |
4 |
severe acute respiratory syndrome - drug therapy - physiopathology - virology |
4 |
severe acute respiratory syndrome coronavirus (sars-cov) |
4 |
severe acute respiratory syndrome coronavirus 2 |
4 |
sexual cycle |
4 |
sirna |
4 |
skin diseases - diagnosis - microbiology |
4 |
skin diseases - microbiology - therapy |
4 |
specific pathogen-free organisms |
4 |
staphylococcal infections - diagnosis - etiology - microbiology |
4 |
staphylococcal-infections-microbiology |
4 |
staphylococcus - drug effects |
4 |
staphylococcus aureus - drug effects - isolation & purification - ultrastructure |
4 |
staphylococcus aureus - isolation & purification |
4 |
staphylococcus-classification |
4 |
stem cell transplantation - adverse effects |
4 |
stomatitis - drug therapy - prevention & control |
4 |
streptococcal infections - epidemiology |
4 |
streptococcal infections - etiology |
4 |
streptococcus - classification - genetics |
4 |
streptococcus - genetics - isolation & purification |
4 |
streptococcus anginosus |
4 |
streptococcus anginosus - genetics - isolation & purification |
4 |
streptococcus bovis - classification - genetics |
4 |
streptococcus milleri |
4 |
streptococcus pneumoniae - drug effects |
4 |
streptococcus pneumoniae/drug effects |
4 |
streptococcus sinensis |
4 |
structural fitness of antibody |
4 |
subcutaneous tissue |
4 |
substance abuse, intravenous - complications |
4 |
sweet's syndrome |
4 |
switzerland - epidemiology |
4 |
synteny |
4 |
t cell exhaustion |
4 |
t cell immunity |
4 |
t cell-mediated response |
4 |
teicoplanin - therapeutic use |
4 |
temporal dynamics |
4 |
tenericutes - classification - isolation & purification |
4 |
th1 cells - immunology |
4 |
th1 cells - immunology - secretion |
4 |
the neisseriaceae family |
4 |
therapeutic irrigation - methods |
4 |
therapeutics |
4 |
tickborne diseases |
4 |
tissue |
4 |
tissue tropism |
4 |
toxin a (tcda) |
4 |
toxin b (tcdb) |
4 |
trans-activators - genetics |
4 |
transaminases - genetics |
4 |
transcriptional activity |
4 |
transformation |
4 |
transgenes |
4 |
transplantation |
4 |
transplantation conditioning - adverse effects - methods |
4 |
transplantation immunology |
4 |
traveller's diarrhoea |
4 |
triazines - administration & dosage - metabolism - urine |
4 |
trichuriasis - complications |
4 |
trichuris - isolation and purification |
4 |
tuberculin test |
4 |
tuberculosis - diagnosis - microbiology |
4 |
tuberculosis, lymph node - diagnosis - drug therapy |
4 |
tuberculosis, meningeal - microbiology |
4 |
tuberculosis, miliary - diagnosis - drug therapy |
4 |
tuberculosis, multidrug-resistant - diagnosis - microbiology |
4 |
tuberculosis, pulmonary - diagnosis - microbiology |
4 |
tuberculosis, pulmonary - drug therapy - etiology - immunology - physiopathology - |
4 |
tumor cells, cultured |
4 |
tumor virus infections - etiology - pathology |
4 |
typhoid fever - microbiology |
4 |
united arab emirates |
4 |
up-regulation |
4 |
urinary bladder - metabolism - pathology |
4 |
urinary tract infections - diagnosis - urine - virology |
4 |
uterine cervical neoplasms - complications - radiotherapy |
4 |
vaccines, dna - immunology |
4 |
vaccines, synthetic - immunology |
4 |
vancomycin - therapeutic use |
4 |
varicella zoster virus |
4 |
varicella-zoster virus |
4 |
veillonellaceae |
4 |
vero cells |
4 |
verocytotoxigenic escherichia coli |
4 |
vidarabine - adverse effects - analogs & derivatives |
4 |
viral envelope proteins - chemistry |
4 |
viral kinetics |
4 |
viral matrix proteins - immunology - metabolism |
4 |
viral proteins - chemistry - genetics - metabolism |
4 |
viral vaccines - immunology |
4 |
virology - methods |
4 |
virology - methods - standards |
4 |
virus activation |
4 |
virus activation - drug effects |
4 |
virus activation - physiology |
4 |
virus assembly |
4 |
virus replication - immunology |
4 |
vps34 |
4 |
wolbachia |
4 |
world health |
4 |
zoonoses - epidemiology - transmission - virology |
4 |
β-lactams |
4 |
γδ t cell |
4 |
16s rrna gene sequencing |
3 |
2-propanol - pharmacology |
3 |
acinetobacter - drug effects - genetics - isolation and purification |
3 |
acinetobacter baumannii |
3 |
acinetobacter infections - epidemiology |
3 |
actinobacteria - classification - genetics - isolation & purification |
3 |
actinobacteria - genetics |
3 |
actinomyces - classification - genetics - isolation & purification |
3 |
actinomycetales - classification - genetics - isolation & purification |
3 |
actinomycetales - classification - genetics - isolation & purification - pathogenicity |
3 |
actinomycetales infections - etiology - microbiology |
3 |
actinomycosis - diagnosis - microbiology |
3 |
acupuncture analgesia - adverse effects |
3 |
acute cholangitis |
3 |
acute disseminated encephalomyelitis |
3 |
acute kidney injury |
3 |
acyltransferases - genetics - metabolism - toxicity |
3 |
adeno-associated viral vector |
3 |
adenoviridae - genetics |
3 |
adenoviruses, human - isolation & purification |
3 |
administration, intranasal |
3 |
administration, topical |
3 |
adult croup |
3 |
adverse effect |
3 |
aedes |
3 |
agar |
3 |
age distribution |
3 |
aids-related opportunistic infections - epidemiology - microbiology |
3 |
aids-related opportunistic infections - microbiology |
3 |
air |
3 |
airborne |
3 |
albendazole |
3 |
alcohol hand rub |
3 |
alcohols - therapeutic use |
3 |
allergens |
3 |
allogeneic |
3 |
amino acid deletion |
3 |
amino terminal sequence |
3 |
amoxicillin - administration & dosage - therapeutic use |
3 |
amoxicillin-potassium clavulanate combination |
3 |
amphotericin b - administration & dosage |
3 |
amphotericin b - therapeutic use |
3 |
ampicillin |
3 |
ampicillin - pharmacology |
3 |
ampicillin resistance |
3 |
amplityping |
3 |
analysis of variance |
3 |
androstadienes - administration & dosage - therapeutic use |
3 |
animal rna virus |
3 |
anti-aquaporin-4 antibody |
3 |
anti-bacterial agents - administration & dosage |
3 |
anti-bacterial agents - analysis - biosynthesis |
3 |
anti-bacterial agents - immunology - pharmacology |
3 |
anti-bacterial agents - metabolism - pharmacology |
3 |
anti-hiv agents - pharmacology |
3 |
anti-inflammatory agents - administration & dosage - therapeutic use |
3 |
antibiotic control |
3 |
antibiotics, antitubercular - pharmacology |
3 |
antibodies, bacterial - biosynthesis - immunology |
3 |
antibodies, bacterial - blood |
3 |
antibodies, viral - immunology |
3 |
antibody formation - drug effects |
3 |
antibody formation - immunology |
3 |
antifungal |
3 |
antifungal prescription |
3 |
antigen-antibody complex - immunology |
3 |
antigens, bacterial - immunology |
3 |
antigens, fungal - chemistry - genetics - immunology |
3 |
antineoplastic agents, alkylating - toxicity |
3 |
antiporters - genetics |
3 |
antiretroviral therapy, highly active |
3 |
antiretroviral therapy, highly active - classification - methods |
3 |
aortic aneurysm, abdominal - microbiology |
3 |
appendicitis - complications - microbiology |
3 |
appendicitis - etiology |
3 |
arthritis, infectious - drug therapy - etiology - microbiology |
3 |
ascomycota |
3 |
ascomycota - genetics |
3 |
asia, southeastern - epidemiology |
3 |
aspergillosis - complications - drug therapy |
3 |
aspergillosis - diagnosis |
3 |
aspergillosis - diagnosis - drug therapy - etiology |
3 |
aspergillus - drug effects - growth & development |
3 |
aspergillus fumigatus - classification - genetics |
3 |
aspergillus fumigatus - genetics - immunology - ultrastructure |
3 |
aspergillus fumigatus - immunology |
3 |
asthma |
3 |
atp-binding cassette transporters |
3 |
autophagy |
3 |
autophagy - immunology |
3 |
avian influenza a h9n2 |
3 |
avian influenza h7n9 |
3 |
bacteremia - complications - drug therapy - epidemiology |
3 |
bacteremia - complications - drug therapy - microbiology |
3 |
bacteremia - diagnosis - drug therapy - epidemiology |
3 |
bacteremia - diagnosis - epidemiology - microbiology |
3 |
bacteremia - etiology - microbiology |
3 |
bacteremia-microbiology |
3 |
bacteria - classification - genetics - isolation & purification - metabolism |
3 |
bacteria - drug effects |
3 |
bacteria - pathogenicity |
3 |
bacteria, anaerobic - classification - isolation & purification |
3 |
bacteria,-anaerobic-classification |
3 |
bacterial gene |
3 |
bacterial infections |
3 |
bacterial strain |
3 |
bacterial toxins - genetics - metabolism - toxicity |
3 |
bacterial typing techniquesy |
3 |
bacterial vaccines - immunology |
3 |
bacterial-toxins-biosynthesis |
3 |
bacterial-typing-techniques-methods |
3 |
bacterium examination |
3 |
bacterium identification |
3 |
bacterium isolation |
3 |
bacteriuria - epidemiology - microbiology |
3 |
bangladesh |
3 |
beauty |
3 |
benzoates - therapeutic use |
3 |
beta-lactam resistance - genetics |
3 |
beta-lactamases - analysis - antagonists & inhibitors |
3 |
beta-lactamases - genetics |
3 |
biliary tract disease |
3 |
biliary tract diseases - complications |
3 |
bioinformatics |
3 |
biological evolution |
3 |
bk virus |
3 |
bk virus - genetics - isolation & purification - physiology |
3 |
bkv |
3 |
blood transfusion - adverse effects |
3 |
bloodstream isolates |
3 |
breast milk |
3 |
bronchiectasis - drug therapy - immunology - microbiology - pathology |
3 |
bronchoalveolar lavage fluid - virology |
3 |
bronchoscopy |
3 |
burkholderia - classification - genetics - isolation and purification |
3 |
burkholderia infections - diagnosis - microbiology |
3 |
burkholderia pseudomallei - chemistry - classification - genetics |
3 |
burkholderia pseudomallei - classification - genetics - isolation & purification |
3 |
burkholderia pseudomallei - drug effects |
3 |
burkholderia pseudomallei - enzymology - genetics - isolation & purification |
3 |
burkholderia pseudomallei - genetics - immunology |
3 |
ca-mrsa |
3 |
campylobacter infections - diagnosis - drug therapy - epidemiology |
3 |
campylobacter jejuni - drug effects - isolation & purification |
3 |
candida - isolation & purification |
3 |
candida - pathogenicity |
3 |
candida albicans - pathogenicity |
3 |
candidiasis - complications - microbiology |
3 |
candidiasis, oral - microbiology |
3 |
carbapenemase |
3 |
carrier proteins - chemistry - genetics - immunology - metabolism |
3 |
carrier state - epidemiology - microbiology |
3 |
carrier state - virology |
3 |
cat diseases |
3 |
catalase - genetics |
3 |
catheters, indwelling - microbiology |
3 |
ccr5 polymorphism |
3 |
cd4-positive t-lymphocytes - immunology |
3 |
cd8-positive t-lymphocytes - immunology |
3 |
cefotaxime - therapeutic use |
3 |
ceftazidime - metabolism |
3 |
ceftriaxone - therapeutic use |
3 |
cell adhesion |
3 |
cell lineage - genetics |
3 |
cell wall |
3 |
cell wall - physiology |
3 |
celllulitis |
3 |
cellulitis - diagnosis - microbiology |
3 |
cellulitis - drug therapy - etiology - microbiology |
3 |
cestodes |
3 |
chemokine ccl5 - blood - genetics |
3 |
chemokine cxcl10 - biosynthesis |
3 |
chickenpox vaccine - administration & dosage |
3 |
chimney effect |
3 |
china - ethnology |
3 |
chinese wet-market |
3 |
cholangitis - complications |
3 |
cholera - complications - microbiology |
3 |
cholera toxin - genetics |
3 |
chromatography, high pressure liquid |
3 |
chronic graft versus host disease |
3 |
cilia |
3 |
cladribine - adverse effects |
3 |
clarithromycin - administration & dosage - therapeutic use |
3 |
clarithromycin - immunology - pharmacology |
3 |
clavulanic acid - administration & dosage - therapeutic use |
3 |
clinical article |
3 |
clostridium - classification - genetics - isolation & purification |
3 |
clostridium - classification - isolation & purification - pathogenicity |
3 |
clostridium difficile - drug effects - growth & development |
3 |
clostridium infections - diagnosis - epidemiology - microbiology |
3 |
co-trimoxazole |
3 |
codon usage bias |
3 |
colitis - microbiology - pathology |
3 |
combination antiretroviral therapy |
3 |
combinational therapy |
3 |
communicable diseases, emerging - prevention & control - transmission |
3 |
community-acquired infections - diagnosis - epidemiology - virology |
3 |
community-acquired legionellosis |
3 |
comparative genomic hybridization |
3 |
conjunctivitis, bacterial - diagnosis - microbiology |
3 |
cord blood transplant |
3 |
coreceptor function |
3 |
coronaviridae - classification - genetics |
3 |
coronavirus - isolation & purification |
3 |
coronavirus infections - diagnosis - epidemiology - virology |
3 |
cox1 gene |
3 |
cpg islands |
3 |
cpg suppression |
3 |
crf01_ae |
3 |
cross infection - diagnosis |
3 |
cross infection - epidemiology - prevention & control |
3 |
croup |
3 |
croup - diagnosis - therapy - virology |
3 |
cxcl10 |
3 |
cyclophosphamide |
3 |
cyclophosphamide - toxicity |
3 |
cysteine endopeptidases |
3 |
cystitis - epidemiology - microbiology |
3 |
cystitis - etiology - prevention & control - virology |
3 |
cystitis - etiology - urine |
3 |
cytokine-induced killer cell therapy |
3 |
cytokines - biosynthesis |
3 |
cytokines - biosynthesis - genetics - secretion |
3 |
cytomegalovirus infections - virology |
3 |
cytosine - chemistry |
3 |
cytosine deamination |
3 |
cytotoxins-biosynthesis |
3 |
d614g |
3 |
databases, genetic |
3 |
dependovirus - genetics |
3 |
dependovirus - genetics - immunology |
3 |
dependovirus - genetics - metabolism |
3 |
dermatophyte |
3 |
diagnostic test |
3 |
dialysis solutions |
3 |
diarrhea-microbiology |
3 |
directly observed hand hygiene |
3 |
directly observed therapy - methods |
3 |
disease reservoirs - microbiology |
3 |
disease transmission, infectious |
3 |
disinfectants - pharmacology |
3 |
dna technology |
3 |
dna transposable elements - genetics |
3 |
dna, fungal - genetics - isolation & purification |
3 |
dna, recombinant - genetics |
3 |
dna, recombinant - immunology |
3 |
dna,-bacterial-genetics |
3 |
dna-directed rna polymerases - chemistry - genetics |
3 |
dose optimization |
3 |
dose-response relationship, drug |
3 |
drainage system |
3 |
drinking water |
3 |
droplet |
3 |
drug contamination |
3 |
drug resistance |
3 |
drug resistance, microbial - genetics |
3 |
drug resistance, multiple |
3 |
early clinical diagnosis |
3 |
ebola virus disease |
3 |
ebolavirus |
3 |
eggerthella bactermia |
3 |
elbow |
3 |
electronics - instrumentation - methods - organization and administration |
3 |
encephalitis, herpes simplex - complications - immunology |
3 |
encephalomyelitis, acute disseminated - diagnosis - etiology - virology |
3 |
endocarditis - drug therapy - etiology - microbiology |
3 |
endopeptidases - metabolism |
3 |
enterobacteriaceae - drug effects - genetics |
3 |
enterobacteriaceae infections - diagnosis - drug therapy - microbiology |
3 |
enterobacteriaceae infections - epidemiology - metabolism |
3 |
enterococcus - classification - drug effects - isolation & purification |
3 |
enterococcus faecium - growth & development - pathogenicity |
3 |
enterocolitis, pseudomembranous - microbiology |
3 |
environmental hygiene |
3 |
enzyme inhibitors - pharmacology |
3 |
epidemic |
3 |
epithelial cells |
3 |
epithelium - microbiology |
3 |
epitopes - immunology |
3 |
equipment contamination |
3 |
erythema nodosum |
3 |
erythromycin |
3 |
escherichia coli - classification - genetics - isolation and purification |
3 |
escherichia coli - drug effects - enzymology |
3 |
escherichia coli - drug effects - genetics |
3 |
escherichia coli - enzymology - genetics |
3 |
escherichia coli - growth & development - isolation & purification |
3 |
escherichia coli infections - complications - diagnosis - epidemiology - microbiology |
3 |
escherichia coli infections - epidemiology - microbiology |
3 |
escherichia coli proteins - genetics |
3 |
escherichia coli proteins - immunology |
3 |
escherichia-coli-infections-microbiology |
3 |
escherichia-coli-o157-metabolism |
3 |
evolutionary rate |
3 |
exanthema - diagnosis - microbiology |
3 |
exophiala - drug effects - isolation & purification |
3 |
expression and conformation |
3 |
extended-spectrum beta-lactamase |
3 |
facility design and construction |
3 |
false negative reactions |
3 |
fatal infection |
3 |
fecal aerosol |
3 |
fetal blood - microbiology |
3 |
fever of unknown origin - etiology |
3 |
flagellin - genetics |
3 |
fluorescent antibody technique, direct |
3 |
fluorogenic substrate |
3 |
forecasting |
3 |
fungal proteins - analysis - genetics - immunology - metabolism |
3 |
fungal proteins - chemistry - genetics - immunology |
3 |
fungal proteins - immunology |
3 |
fungal structures - cytology |
3 |
fungemia - complications - microbiology |
3 |
fungemia - diagnosis - microbiology |
3 |
fungi - cytology |
3 |
galactose - metabolism - pharmacology |
3 |
ganciclovir |
3 |
gas chromatography-mass spectrometry |
3 |
gastroenteritis - genetics - microbiology |
3 |
gastrointestinal tract - chemistry - virology |
3 |
gene expression regulation, bacterial - immunology |
3 |
gene expression regulation, viral - drug effects |
3 |
gene transfer, horizontal |
3 |
genes, viral |
3 |
genetic complementation test |
3 |
genetic drift |
3 |
genetic speciation |
3 |
genetic techniques |
3 |
genomic analysis |
3 |
genotyping resistance test |
3 |
gentamicins - administration & dosage - therapeutic use |
3 |
glucocorticoids - therapeutic use |
3 |
graft vs host disease - virology |
3 |
gram-negative aerobic rods and cocci - isolation & purification |
3 |
gram-negative bacteria - cytology - isolation & purification |
3 |
gram-negative bacterial infections - complications - drug therapy - epidemiology - microbiology |
3 |
gram-positive bacteria - classification - genetics - isolation & purification |
3 |
gram-positive bacteria - cytology - isolation & purification |
3 |
gram-positive bacterial infections - diagnosis - epidemiology - microbiology |
3 |
gram-positive bacterial infections - epidemiology - microbiology |
3 |
gram-positive bacterial infections - epidemiology - prevention & control |
3 |
gram-positive bacterial infections - genetics |
3 |
gram-positive cocci - drug effects - genetics |
3 |
gram-positive-bacteria-classification |
3 |
gram-positive-bacterial-infections-diagnosis |
3 |
gram-positive-bacterial-infections-microbiology |
3 |
granulomatous disease, chronic - immunology |
3 |
groel protein - genetics |
3 |
guideline adherence - organization and administration |
3 |
h1n1 subtype |
3 |
h275y |
3 |
haematopoietic stem cell transplantation |
3 |
haemophilus - classification - genetics - growth & development |
3 |
haemophilus infections - microbiology |
3 |
hafnia alvei - classification - isolation & purification |
3 |
handwashing - standards |
3 |
hematopoietic stem cell transplantation - methods |
3 |
hematuria - etiology - virology |
3 |
hepatitis antibodies |
3 |
hepatitis b antibodies - immunology |
3 |
hepatitis b e antigens - blood - genetics |
3 |
hepatitis b surface antigens - blood - genetics |
3 |
hepatitis b surface antigens - blood - immunology |
3 |
hepatitis b vaccines - immunology |
3 |
hepatitis b vaccines - therapeutic use |
3 |
hepatitis b virus - drug effects - genetics - physiology |
3 |
hepatitis e virus |
3 |
herpes simplex - diagnosis - drug therapy - etiology |
3 |
herpes zoster - prevention & control |
3 |
heterozygote |
3 |
histiocytosis, non-langerhans-cell - microbiology - pathology |
3 |
hiv - metabolism |
3 |
hiv infection |
3 |
hiv infections - drug therapy - virology |
3 |
hiv infections - epidemiology - transmission |
3 |
hiv infections - genetics |
3 |
hiv infections - genetics - metabolism |
3 |
hiv-1 - classification - drug effects - genetics |
3 |
hiv-1 - classification - drug effects - genetics - isolation & purification |
3 |
hiv-1 - classification - genetics - physiology |
3 |
hiv-1 - genetics |
3 |
homozygote |
3 |
housing |
3 |
hpai |
3 |
human betacoronavirus 2c emc/2012 |
3 |
human metapneumovirus |
3 |
humanized mouse |
3 |
hydrolysis |
3 |
hygiene - standards |
3 |
hyperbilirubinemia - complications - microbiology - therapy |
3 |
immune |
3 |
immune responses |
3 |
immunity, cellular - immunology |
3 |
immuno-reconstitution |
3 |
immunocompromised |
3 |
immunoenzyme techniques |
3 |
immunoglobulin g - analysis - biosynthesis |
3 |
in-house |
3 |
infection - transmission |
3 |
infection control - instrumentation - methods - organization and administration - standards |
3 |
infection control measure |
3 |
infectious disease transmission, patient-to-professional - prevention & control |
3 |
infectious mononucleosis - physiopathology - virology |
3 |
inflammation - drug therapy - etiology |
3 |
inflammation - prevention & control |
3 |
influenza a virus - immunology |
3 |
influenza a virus, h1n1 subtype - drug effects - genetics - immunology |
3 |
influenza a virus, h9n2 subtype - classification - genetics - isolation and purification |
3 |
influenza b |
3 |
influenza, human - complications - diagnosis - pathology - virology |
3 |
influenza, human - diagnosis - epidemiology - transmission - virology |
3 |
influenza, human - epidemiology - immunology - prevention and control - therapy |
3 |
influenza, human - immunology - virology |
3 |
influenza, human - prevention & control - transmission |
3 |
inh resistance |
3 |
inhibitory concentration 50 |
3 |
insertion sequence |
3 |
integrin 4β7 |
3 |
interferon-alpha - biosynthesis |
3 |
interferon-gamma - biosynthesis |
3 |
interleukin-4 - biosynthesis |
3 |
internet |
3 |
intestinal mucosa - drug effects |
3 |
intrauterine devices - microbiology |
3 |
is6110 |
3 |
isbp1 |
3 |
iterferon gamma |
3 |
ivig |
3 |
jaundice - complications - microbiology - therapy |
3 |
jc virus - isolation & purification |
3 |
katg |
3 |
keratinolytic |
3 |
kidney failure, acute - microbiology |
3 |
kidney failure, chronic - diagnosis - therapy |
3 |
kidney failure, chronic - therapy |
3 |
klebsiella infections - complications - diagnosis - drug therapy |
3 |
klebsiella pneumoniae - drug effects - enzymology |
3 |
klebsiella pneumoniae - drug effects - isolation & purification |
3 |
knee - microbiology - pathology |
3 |
lactobacillus - classification - genetics - isolation & purification |
3 |
lactobacillus fermentum |
3 |
leukemia - therapy |
3 |
leukemia, myelogenous, chronic, bcr-abl positive - complications - therapy |
3 |
leukemia, myeloid - complications - therapy |
3 |
leukemia, myeloid, acute - complications - therapy |
3 |
lineage specificity |
3 |
linear models |
3 |
lipopolysaccharides - immunology |
3 |
live attenuated s. typhimurium vaccine |
3 |
live-attenuated salmonella |
3 |
long-term care |
3 |
long-term care facilities |
3 |
lopinavir‐ritonavir |
3 |
lung diseases, fungal - diagnosis - drug therapy - etiology |
3 |
lupus erythematosus, systemic - complications |
3 |
lymphedema - complications |
3 |
maba-inha |
3 |
macrophages - immunology - microbiology - secretion |
3 |
macrophages - microbiology |
3 |
main protease |
3 |
maltose-binding proteins |
3 |
management |
3 |
mastectomy - adverse effects |
3 |
melanin |
3 |
melanins - biosynthesis |
3 |
melioidosis - diagnosis |
3 |
melioidosis - diagnosis - microbiology |
3 |
membrane glycoproteins - administration & dosage - immunology |
3 |
membrane glycoproteins - administration and dosage - genetics - immunology |
3 |
membrane glycoproteins - analysis - genetics - immunology - metabolism |
3 |
mental disorders |
3 |
metapneumovirus - classification - pathogenicity |
3 |
metapneumovirus - pathogenicity |
3 |
methicillin resistance - genetics |
3 |
methylmethacrylates - metabolism |
3 |
metronidazole - pharmacology |
3 |
mice, inbred balb/c |
3 |
microarray |
3 |
microbial viability - drug effects |
3 |
microbiology medical sciences |
3 |
microscopy - methods |
3 |
microscopy, immunoelectron |
3 |
middle east respiratory syndrome |
3 |
mlst |
3 |
models, biological |
3 |
models, theoretical |
3 |
molecular diagnosis |
3 |
monosaccharide transport proteins |
3 |
monte carlo method |
3 |
mouth mucosa - cytology - microbiology |
3 |
mouth mucosa - metabolism |
3 |
mp1p enzyme immunoassay |
3 |
mucositis |
3 |
multidrug-resistant |
3 |
multilocus sequence typing - methods |
3 |
multiple myeloma - complications - diagnosis |
3 |
multiple myeloma - complications - immunology |
3 |
multiplex allele-specific pcr |
3 |
multiplex pcr |
3 |
mycobacterial rna polymerase |
3 |
mycobacterium |
3 |
mycobacterium - classification - genetics - isolation & purification |
3 |
mycobacterium abscessus |
3 |
mycobacterium avium complex - chemistry - classification - genetics - isolation & purification |
3 |
mycobacterium avium-intracellulare infection - diagnosis |
3 |
mycobacterium chelonae - drug effects |
3 |
mycobacterium haemophilum - genetics - isolation and purification |
3 |
mycobacterium infections - diagnosis - drug therapy - microbiology - pathology |
3 |
mycobacterium infections - diagnosis - microbiology |
3 |
mycobacterium marinum - genetics - isolation and purification |
3 |
mycobacterium marinum - genetics - metabolism - pathogenicity |
3 |
mycobacterium smegmatis |
3 |
mycobacterium smegmatis - genetics |
3 |
mycobacterium smegmatis - genetics - metabolism - pathogenicity |
3 |
mycobacterium tuberculosis - chemistry - classification - genetics - isolation & purification |
3 |
mycobacterium tuberculosis - drug effects - isolation & purification |
3 |
mycobacterium tuberculosis - genetics - growth and development - isolation and purification - pathogenicity |
3 |
mycobacterium tuberculosis - genetics - immunology - isolation & purification - pathogenicity |
3 |
mycological typing techniques |
3 |
mycology - methods |
3 |
mycoses - blood - diagnosis - microbiology |
3 |
mycoses - complications - microbiology - pathology |
3 |
mycoses - diagnosis - drug therapy |
3 |
mycoses - diagnosis - drug therapy - immunology - microbiology |
3 |
mycoses - mortality |
3 |
myeloablative agonists - adverse effects |
3 |
n-terminal domain |
3 |
nematodes |
3 |
neoplasms - complications |
3 |
neuraminidase |
3 |
neuraminidase - genetics - immunology - metabolism |
3 |
neuromyelitis optica |
3 |
nosocomial legionellosis |
3 |
nuclear localization signal |
3 |
nucleic acid hybridization |
3 |
opportunistic infections - diagnosis - drug therapy - etiology |
3 |
opportunistic infections - etiology - virology |
3 |
opportunistic infections - microbiology |
3 |
orf3a |
3 |
orf3b |
3 |
orthomyxoviridae infections - immunology |
3 |
oxidoreductases - genetics |
3 |
pancytopenia |
3 |
pandemics |
3 |
para-influenza virus |
3 |
parainfluenza virus 3, human |
3 |
parainfluenza virus 3, human - isolation & purification |
3 |
parainfluenza virus type 3 |
3 |
paramyxoviridae - genetics - isolation and purification |
3 |
paramyxoviridae infections - chemically induced - complications |
3 |
paramyxoviridae infections - diagnosis - epidemiology - veterinary - virology |
3 |
paramyxoviridae infections - physiopathology - virology |
3 |
paramyxoviridae infections - prevention & control |
3 |
paramyxovirinae - genetics - isolation and purification |
3 |
penicillins - pharmacology |
3 |
penicilliosis |
3 |
penicillium - classification - drug effects - growth & development - metabolism |
3 |
penicillium - classification - genetics - isolation & purification |
3 |
penicillium - classification - genetics - pathogenicity - physiology |
3 |
penicillium - classification - isolation & purification |
3 |
penicillium - drug effects - genetics - pathogenicity - radiation effects |
3 |
penicillium - genetics - growth and development - pathogenicity |
3 |
peptides to t cell epitopes |
3 |
periplasmic binding proteins |
3 |
peritoneal dialysis |
3 |
peritonitis |
3 |
peritonitis - diagnosis - drug therapy - etiology |
3 |
peritonitis - drug therapy - microbiology |
3 |
phagocytes - physiology |
3 |
plasma exchange |
3 |
plasmapheresis |
3 |
plesiomonas - isolation & purification |
3 |
pneumonia, viral - diagnosis - drug therapy - etiology |
3 |
pneumonia, viral - diagnosis - epidemiology - virology |
3 |
point mutation - genetics |
3 |
polyketide synthase |
3 |
polyketide synthases - genetics |
3 |
polymorphism, genetic - genetics |
3 |
polyomavirus infections - complications - urine - virology |
3 |
polyomavirus infections - drug therapy - etiology |
3 |
polyomavirus infections - drug therapy - virology |
3 |
polyomavirus infections - etiology |
3 |
polyomavirus infections - immunology - urine - virology |
3 |
postoperative complications - drug therapy - etiology |
3 |
postoperative complications - microbiology |
3 |
prednisolone - therapeutic use |
3 |
pregnanc - complications, infectious - diagnosis - drug therapy |
3 |
pregnancy outcome |
3 |
preservation, biological - methods |
3 |
proactive infection control |
3 |
pseudomonas aeruginosa |
3 |
psychiatric department, hospital |
3 |
pulsed-field gel electrophoresis |
3 |
q57h |
3 |
quaternary epitope |
3 |
quinolones - pharmacology |
3 |
ralstonia pickettii |
3 |
random allocation |
3 |
rats, sprague-dawley |
3 |
rd207 |
3 |
receptor-binding domain |
3 |
receptors, ccr5 - genetics |
3 |
receptors, virus - genetics - immunology |
3 |
receptors, virus - metabolism |
3 |
recombinant proteins - antagonists & inhibitors - metabolism |
3 |
recombinant proteins - metabolism |
3 |
reference values |
3 |
regression modeling |
3 |
resistance |
3 |
respiratory burst |
3 |
respiratory insufficiency - diagnosis - etiology |
3 |
respiratory tract infections - chemically induced - complications |
3 |
respiratory tract infections - epidemiology - microbiology |
3 |
respiratory viral infection |
3 |
respirovirus infections - etiology |
3 |
rflp analysis |
3 |
rifampin - pharmacology |
3 |
rm-act-1 |
3 |
rna - biosynthesis - genetics |
3 |
rna, ribosomal, 16s - classification |
3 |
rna, ribosomal, 18s - analysis - genetics |
3 |
rna, small interfering - biosynthesis - genetics - pharmacology |
3 |
rna, small interfering - genetics - pharmacology |
3 |
rna, viral - chemistry - genetics |
3 |
rodent diseases - diagnosis - epidemiology - virology |
3 |
rpob transformation |
3 |
rv2820c |
3 |
saccharomyces cerevisiae - classification - genetics |
3 |
saesxa |
3 |
saesxb |
3 |
safety |
3 |
salmonella - classification - isolation & purification |
3 |
salmonella enterica - classification - isolation & purification - physiology |
3 |
salmonella enterica - immunology |
3 |
salmonella infections - diagnosis - drug therapy - microbiology |
3 |
salmonella infections - epidemiology - microbiology |
3 |
salmonella typhi |
3 |
salmonella typhi - classification - isolation & purification |
3 |
salmonella typhi - immunology |
3 |
salmonella typhimurium - genetics - immunology |
3 |
salpingitis - microbiology |
3 |
sarcoptes scabiei |
3 |
sars virus - drug effects - genetics - physiology |
3 |
sars virus - drug effects - physiology |
3 |
sars virus - enzymology |
3 |
scabies - diagnosis - drug therapy |
3 |
scarlet fever - complications - diagnosis |
3 |
sentinel surveillance |
3 |
septic arthritis |
3 |
sequence analysis, dna - methods |
3 |
serologic tests |
3 |
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control |
3 |
severe acute respiratory syndrome - epidemiology - immunology - prevention & control |
3 |
severe acute respiratory syndrome - immunology - prevention & control |
3 |
severe acute respiratory syndrome - immunology - prevention & control - virology |
3 |
severe acute respiratory syndrome - prevention & control - transmission |
3 |
severe acute respiratory syndrome - prevention and control |
3 |
sex distribution |
3 |
shigella flexneri - drug effects - enzymology - isolation & purification |
3 |
siblings |
3 |
skin diseases, bacterial - diagnosis - microbiology - pathology |
3 |
small molecule inhibitor |
3 |
snake |
3 |
spectrometry, fluorescence - methods |
3 |
spitting behavior |
3 |
spores, fungal - drug effects - genetics - radiation effects - ultrastructure |
3 |
sputum |
3 |
sputum - cytology - drug effects - immunology - microbiology |
3 |
sputum - microbiology |
3 |
sputum pathogens |
3 |
st414 |
3 |
staff education |
3 |
staphylococcaceae - drug effects - genetics |
3 |
staphylococcaceae - genetics |
3 |
staphylococcal infections - diagnosis |
3 |
staphylococcal skin infections - epidemiology - microbiology |
3 |
streptococcal infections - diagnosis - drug therapy - epidemiology |
3 |
streptococcus agalactiae - classification - isolation & purification |
3 |
streptococcus pyogenes - classification - genetics - isolation & purification |
3 |
strongyloidiasis |
3 |
subdomain 1 |
3 |
surgical site abscess |
3 |
surveillance |
3 |
survival analysis |
3 |
swine origin influenza virus a/h1n1 |
3 |
synovitis - etiology |
3 |
t3ss |
3 |
talaromycosis |
3 |
telomere - genetics |
3 |
teta gene |
3 |
tetr gene |
3 |
tetracycline resistance - genetics |
3 |
therapeutic vaccine |
3 |
thermus thermophilus - genetics |
3 |
toxic scarlet fever |
3 |
transformation, bacterial - genetics |
3 |
transient immunodeficiency |
3 |
transplantation, autologous |
3 |
transplantation, liver |
3 |
treatment failure |
3 |
trimethoprim-sulfamethoxazole combination - pharmacology |
3 |
tuberculosis - diagnosis |
3 |
tuberculosis - immunology |
3 |
tuberculosis - microbiology |
3 |
tuberculosis, splenic - complications - diagnosis - drug therapy |
3 |
tumor virus infections - complications - urine - virology |
3 |
tumor virus infections - drug therapy - etiology |
3 |
tumor virus infections - drug therapy - virology |
3 |
tumor virus infections - immunology - urine - virology |
3 |
typhoid fever - drug therapy - immunology |
3 |
typhoid fever - etiology |
3 |
typing |
3 |
ultraviolet rays |
3 |
urban population |
3 |
vaccination - statistics & numerical data |
3 |
vaccines |
3 |
vaccines, attenuated - immunology |
3 |
vaccines, inactivated - administration & dosage |
3 |
vancomycin - pharmacology |
3 |
vancomycin-resistant enterococcus faecium |
3 |
vancomycin-resistant staphylococcus aureus |
3 |
vasculitis, leukocytoclastic, cutaneous - drug therapy - microbiology |
3 |
vedolizumab |
3 |
vibrio cholerae - classification |
3 |
vibrio cholerae - genetics - metabolism |
3 |
victoria lineage |
3 |
viral envelope proteins - administration & dosage - immunology |
3 |
viral envelope proteins - administration and dosage - genetics - immunology |
3 |
viral infections |
3 |
viral matrix proteins - genetics - immunology |
3 |
viral proteins - antagonists & inhibitors - metabolism |
3 |
viral proteins - genetics - immunology - metabolism |
3 |
viral vaccines - administration & dosage - immunology |
3 |
viral vaccines - administration & dosage - immunology - pharmacology |
3 |
viral vaccines - administration and dosage - genetics - immunology |
3 |
virulence attributes |
3 |
virus latency |
3 |
vocal cords - pathology |
3 |
voice disorders - diagnosis - etiology - virology |
3 |
waldenstrom macroglobulinemia - complications - microbiology |
3 |
water buffalo |
3 |
water supply |
3 |
water supply - standards |
3 |
weil disease - complications - therapy |
3 |
west africa |
3 |
zoonoses - transmission - virology |
3 |
16s |
2 |
16s ribosomal rna sequencing |
2 |
16s rrna |
2 |
16s rrna sequencing |
2 |
accidents, traffic |
2 |
acetamides - pharmacology |
2 |
acquired immunodeficiency syndrome - complications - drug therapy |
2 |
acremonium - isolation & purification |
2 |
actinomycetales infections - complications |
2 |
actinomycetales infections - drug therapy - radiography |
2 |
acute myeloid leukemia |
2 |
adamantane |
2 |
adaptationautophagy |
2 |
adefovir dipivoxil |
2 |
adefovir dipivoxil plus emtricitabine |
2 |
adenine - administration & dosage - adverse effects - analogs & derivatives - therapeutic use |
2 |
aids-related opportunistic infections - diagnosis - drug therapy - microbiology |
2 |
aids-related opportunistic infections - diagnosis - microbiology |
2 |
aids-related opportunistic infections - diagnosis - microbiology - physiopathology |
2 |
air microbiology |
2 |
alanine transaminase - blood |
2 |
alcohol consumption |
2 |
alcoholism - complications |
2 |
allograft skin |
2 |
amikacin - therapeutic use |
2 |
amino acids - genetics - immunology |
2 |
amphotericin b |
2 |
anemia, hemolytic, autoimmune - diagnosis - drug therapy |
2 |
anemia, refractory, with excess of blasts - microbiology |
2 |
animal-diseases-transmission |
2 |
ant venoms - toxicity |
2 |
anti-bacterial agents - adverse effects - therapeutic use |
2 |
anti-hiv agents - therapeutic use |
2 |
anti-inflammatory agents - therapeutic use |
2 |
antibodies, monoclonal - genetics - immunology |
2 |
antibodies, viral - therapeutic use |
2 |
antigenic sites |
2 |
antigenic variation |
2 |
antigens, fungal - analysis |
2 |
antigens, fungal - analysis - genetics - immunology |
2 |
antigens, fungal - cerebrospinal fluid |
2 |
antigens, viral - biosynthesis |
2 |
antigens, viral - blood - drug effects |
2 |
antimicrobial resistance epidemiology |
2 |
antiviral agents - administration & dosage - therapeutic use |
2 |
ants |
2 |
arcobacter - classification - genetics - isolation & purification |
2 |
aspergillosis - complications - diagnosis |
2 |
aspergillosis - diagnosis - epidemiology - prevention & control |
2 |
aspergillosis - immunology - microbiology |
2 |
aspergillus - immunology - isolation and purification |
2 |
aspergillus flavus - isolation and purification |
2 |
bacteremia - complications |
2 |
bacteremia - diagnosis - drug therapy - etiology |
2 |
bacteremia - etiology |
2 |
bacterial infections - epidemiology |
2 |
bacterial toxins - genetics |
2 |
bacteriuria - microbiology |
2 |
base sequence - genetics |
2 |
beta-lactamases - chemistry - genetics - metabolism |
2 |
biological sciences |
2 |
biotin - metabolism |
2 |
blood and marrow transplant |
2 |
blood donors - statistics & numerical data |
2 |
blood platelets - drug effects |
2 |
body modification |
2 |
body piercing |
2 |
body temperature - drug effects |
2 |
bone marrow |
2 |
bone marrow hypoplasia |
2 |
breast |
2 |
breast implants |
2 |
british columbia - epidemiology |
2 |
burns |
2 |
buttocks |
2 |
c-reactive protein - analysis |
2 |
cambodia |
2 |
candidiasis - diagnosis - microbiology |
2 |
capsid proteins |
2 |
cardiac surgical procedures - adverse effects |
2 |
catheter-associated infection |
2 |
catheterization, peripheral - adverse effects |
2 |
cell membrane - metabolism |
2 |
cell transformation, viral |
2 |
cerebrospinal fluid shunts - methods |
2 |
chaphamaparvovirus |
2 |
chemoprophylaxis |
2 |
chickenpox |
2 |
chickens |
2 |
chromogenic agar |
2 |
chronic alcoholism |
2 |
chronic lymphatic leukemia |
2 |
cirrhosis |
2 |
clinical practice |
2 |
clostridium - isolation & purification |
2 |
clostridium clostridiiforme |
2 |
clostridium infections - epidemiology - etiology |
2 |
clostridium infections - etiology |
2 |
cmv dnaemia |
2 |
cobas amplicor™ |
2 |
codon |
2 |
colchicine |
2 |
colchicine - poisoning |
2 |
colonoscopy |
2 |
colony-forming units assay |
2 |
combined modality therapy |
2 |
communicable disease control - methods |
2 |
communicable diseases, emerging - diagnosis - epidemiology - therapy |
2 |
community-acquired infections - epidemiology - microbiology - transmission |
2 |
compliance |
2 |
coronavirus 229e, human - metabolism |
2 |
coronavirus infections - metabolism |
2 |
corynebacteria |
2 |
crf01-ae |
2 |
crocodile |
2 |
cross infection - diagnosis - microbiology |
2 |
cross infection - microbiology - transmission |
2 |
cross infection - virology |
2 |
cross species transmission |
2 |
cryptococcaemia |
2 |
cryptococcal meningitis |
2 |
cryptococcus neoformans - classification - genetics - immunology - isolation & purification |
2 |
crystallography, x-ray |
2 |
cyclosporine |
2 |
cytomegalic endothelial cell |
2 |
cytomegalovirus - classification - genetics - isolation and purification |
2 |
cytomegalovirus - drug effects - genetics - immunology - isolation & purification |
2 |
cytomegalovirus - genetics |
2 |
cytomegalovirus - immunology - isolation & purification |
2 |
cytomegalovirus infections - diagnosis - drug therapy - immunology - virology |
2 |
cytomegalovirus infections - epidemiology |
2 |
cytoplasmic granules - metabolism |
2 |
debridement - methods |
2 |
dentistry |
2 |
deoxycytidine - administration & dosage - adverse effects - analogs & derivatives |
2 |
diabetes complications |
2 |
diabetes mellitus - immunology |
2 |
diamond-blackfan syndrome |
2 |
diarrhea - immunology - microbiology |
2 |
diarrhea - pathology - virology |
2 |
diarrhoea |
2 |
disease re-emergence |
2 |
disease transmission, infectious - prevention & control |
2 |
disease-free survival |
2 |
dna probes |
2 |
dna, viral |
2 |
doxycycline - therapeutic use |
2 |
drug sensitivity |
2 |
drug-drug interactions |
2 |
economic development |
2 |
empowered patients |
2 |
empyema |
2 |
enfuvirtide |
2 |
enteral nutrition |
2 |
enteritis - pathology - virology |
2 |
enterobacter cloacae - classification |
2 |
enterobacteriaceae |
2 |
enterobacteriaceae - classification - genetics - isolation & purification |
2 |
enterobacteriaceae - classification - genetics - isolation & purification - metabolism |
2 |
enterobacteriaceae infections - diagnosis - immunology |
2 |
enterobacteriaceae infections - microbiology |
2 |
enterococcus - drug effects |
2 |
entry inhibitor |
2 |
environment |
2 |
environmental monitoring - methods |
2 |
enzyme-linked immunoassay |
2 |
epidemiological monitoring |
2 |
epitope mapping |
2 |
epitopes - chemistry - genetics - immunology |
2 |
escherichia coli - enzymology - growth & development |
2 |
evan's syndrome |
2 |
evolution analysis |
2 |
exotoxins - genetics |
2 |
extremities - surgery |
2 |
family characteristics |
2 |
family health |
2 |
fanconi anemia - therapy |
2 |
fascia - pathology - surgery |
2 |
fasciitis - complications - microbiology |
2 |
fasciitis - complications - microbiology - pathology |
2 |
fasciitis, necrotizing - diagnosis - etiology - therapy |
2 |
fasciitis, necrotizing - pathology - surgery |
2 |
fatality |
2 |
fibrosis |
2 |
fluorescent antibody technique |
2 |
fluoroquinolones - adverse effects - therapeutic use |
2 |
fontan procedure - adverse effects |
2 |
fungal infection |
2 |
gammaproteobacteria - classification - genetics - isolation & purification - physiology |
2 |
ganciclovir - administration & dosage - therapeutic use |
2 |
gastrointestinal diseases |
2 |
genes, pol |
2 |
gout suppressants - poisoning |
2 |
gp41 |
2 |
graft vs host disease - etiology |
2 |
gram-negative bacterial infections - diagnosis - drug therapy - etiology |
2 |
granuloma, plasma cell - etiology - metabolism - pathology |
2 |
h7n7 |
2 |
ha |
2 |
haart |
2 |
hand hygiene ambassador |
2 |
healthcare worker |
2 |
hemagglutinin glycoproteins, influenza virus - chemistry - genetics - immunology |
2 |
hemagglutinins |
2 |
hemoglobins - drug effects |
2 |
hemoptysis - etiology |
2 |
hemosiderosis |
2 |
hepatitis b e antigens - blood |
2 |
hepatitis b, chronic - complications - virology |
2 |
hepatitis b, chronic - drug therapy - virology |
2 |
herpesvirus 4, human - immunology - isolation & purification - physiology |
2 |
high-touch |
2 |
hiv |
2 |
hiv envelope protein gp41 - genetics - pharmacology |
2 |
hiv infections - complications |
2 |
hiv infections - complications - epidemiology - transmission - virology |
2 |
hiv infections - epidemiology |
2 |
hiv infections - virology |
2 |
hiv protease - genetics |
2 |
hiv-1 - classification - genetics |
2 |
hiv-1 - classification - genetics - isolation & purification |
2 |
hiv-1 - drug effects - genetics - isolation and purification |
2 |
homosexuality, male |
2 |
hotel |
2 |
human bocavirus - genetics - metabolism |
2 |
human-to-human transmission |
2 |
ileal diseases - etiology - metabolism - pathology |
2 |
ileum |
2 |
immunity, active |
2 |
immunity, natural |
2 |
immunization programs |
2 |
immunocompromised host - immunology |
2 |
immunocompromised patient |
2 |
immunodominant positions |
2 |
immunoglobulins - immunology - isolation & purification - therapeutic use |
2 |
immunologic factors - therapeutic use |
2 |
immunomodulators |
2 |
immunosuppression |
2 |
infant, premature |
2 |
infant, premature, diseases - diagnosis - microbiology |
2 |
infection - epidemiology |
2 |
infection-transmission |
2 |
infectious disease transmission, vertical |
2 |
inflammatory pseudotumour |
2 |
inflammatory response |
2 |
influenza a virus - classification - immunology |
2 |
influenza a virus - pathogenicity |
2 |
influenza a virus, avian |
2 |
influenza a virus, h1n1 subtype - metabolism - physiology |
2 |
influenza a virus, h5n1 subtype |
2 |
influenza a virus, h5n1 subtype - drug effects - genetics - immunology - metabolism |
2 |
influenza a virus, h5n1 subtype - genetics - immunology |
2 |
influenza a virus, h5n1 subtype - pathogenicity |
2 |
influenza a virus, h7n7 subtype - pathogenicity |
2 |
influenza a virus, h9n2 subtype |
2 |
influenza a virus, human |
2 |
influenza in birds - drug therapy - epidemiology - prevention & control - transmission |
2 |
influenza in birds - transmission - virology |
2 |
influenza vaccines - administration & dosage - adverse effects |
2 |
influenza, human - diagnosis - immunology - virology |
2 |
influenza, human - drug therapy - epidemiology - prevention & control |
2 |
influenza, human - epidemiology - pathology - prevention & control - therapy |
2 |
influenza, human - immunology - prevention & control |
2 |
influenza, human - prevention & control/virology |
2 |
insect bites and stings - complications |
2 |
interferon type i - therapeutic use |
2 |
interferon-alpha |
2 |
iris |
2 |
itraconazole |
2 |
klebsiella - enzymology - growth & development |
2 |
klebsiella infections |
2 |
klebsiella pneumoniae |
2 |
klebsiella species |
2 |
leg injuries - complications - therapy |
2 |
legionella pneumophila - isolation & purification |
2 |
legionnaires' disease - complications - diagnosis |
2 |
letter |
2 |
leukemia, myelogenous, chronic, bcr-abl positive - therapy |
2 |
leukemia, promyelocytic, acute - therapy |
2 |
leukocidins - genetics |
2 |
leukocytes - drug effects |
2 |
lipoproteins |
2 |
listeria monocytogenes |
2 |
listeriosis - etiology |
2 |
liver cirrhosis |
2 |
liver cirrhosis - complications |
2 |
liver cirrhosis - etiology |
2 |
lung abscess |
2 |
lung abscess - drug therapy - radiography |
2 |
lung diseases - epidemiology |
2 |
lung diseases, fungal - epidemiology |
2 |
lung diseases, fungal - immunology - microbiology |
2 |
lupus |
2 |
lupus erythematosus, systemic - complications - drug therapy |
2 |
lupus erythematosus, systemic - epidemiology - microbiology |
2 |
lupus erythematosus, systemic - virology |
2 |
lymphatic diseases - etiology - metabolism - pathology |
2 |
lymphocytes - immunology |
2 |
lymphohistiocytosis, hemophagocytic - blood - etiology |
2 |
macrophage infectivity potentiator |
2 |
malassezia - isolation & purification |
2 |
mass screening |
2 |
matrix-assisted laser desorption ionization–time of flight |
2 |
mediastinal emphysema - etiology - radiography |
2 |
membrane glycoproteins - analysis - chemistry - metabolism |
2 |
membrane glycoproteins - analysis - genetics - immunology |
2 |
meningitis, bacterial - epidemiology - microbiology - transmission |
2 |
meningitis, cryptococcal - cerebrospinal fluid - diagnosis |
2 |
meningitis, cryptococcal - complications - diagnosis - drug therapy |
2 |
mesotherapy |
2 |
methicillin |
2 |
methicillin-resistant staphylococcus aureus - genetics - isolation & purification |
2 |
mp1p |
2 |
muscle, skeletal |
2 |
mutagenesis, insertional |
2 |
mutual-touch |
2 |
mycobacterium chelonae - isolation & purification |
2 |
mycobacterium infections, atypical - etiology - radiography |
2 |
mycobacterium tuberculosis - genetics - isolation & purification |
2 |
mycoplasma - isolation & purification |
2 |
mycoplasma hominis |
2 |
mycoplasma infections - diagnosis - drug therapy - microbiology |
2 |
mycoses - blood - diagnosis - epidemiology |
2 |
mycoses - complications - drug therapy |
2 |
mycoses - diagnosis - drug therapy - microbiology |
2 |
mycoses - diagnosis - etiology |
2 |
mycoses - diagnosis - microbiology - physiopathology |
2 |
mycoses - epidemiology |
2 |
mycoses - microbiology - transmission |
2 |
nasal vaccine |
2 |
necrosis |
2 |
nephro- lalcinosis |
2 |
nephrocalcinosis - complications |
2 |
nested pcr |
2 |
neuraminidase inhibitors |
2 |
nmr resonance assignment |
2 |
nocardia |
2 |
nocardia infections - epidemiology |
2 |
nocardia infections - transmission |
2 |
nocardia otitidis coviarum |
2 |
normalization of serum alanine aminotransaminase |
2 |
northwestern united states - epidemiology |
2 |
nucleic acid amplification techniques |
2 |
nucleocapsid proteins - analysis - immunology |
2 |
nuclisens easyq™ |
2 |
nutrition disorders - immunology |
2 |
ofloxacin - pharmacology |
2 |
oligonucleotide probes |
2 |
oncogene proteins - genetics |
2 |
oncogene proteins, viral |
2 |
opportunistic infection |
2 |
opportunistic infections - diagnosis/epidemiology |
2 |
opportunistic infections - drug therapy - radiography |
2 |
opportunistic infections - epidemiology |
2 |
orthomyxoviridae infections - transmission - virology |
2 |
oxazolidinones - pharmacology |
2 |
parasites |
2 |
parenteral nutrition, total - adverse effects |
2 |
parvoviridae |
2 |
patient admission |
2 |
patient hand hygiene |
2 |
patient isolation |
2 |
pb2 |
2 |
pcr test |
2 |
penicillium - chemistry - genetics - immunology |
2 |
penicillium - classification |
2 |
penicillium - drug effects - growth & development - isolation & purification |
2 |
penicillium - growth & development - isolation & purification |
2 |
peramivir |
2 |
perianal abscess |
2 |
persons who inject drugs |
2 |
phosphonic acids - administration & dosage - adverse effects - therapeutic use |
2 |
phosphoproteins - blood |
2 |
pneumocystis - immunology |
2 |
pneumocystis jiroveci - isolation & purification |
2 |
pneumocystis jirovecii - *isolation & purification |
2 |
pneumomediastinum |
2 |
pneumonia - epidemiology |
2 |
pneumonia, bacterial - complications - diagnosis - microbiology |
2 |
pneumonia, pneumocystis - diagnosis - drug therapy |
2 |
pneumonia, pneumocystis - diagnosis/epidemiology |
2 |
pneumothorax |
2 |
pol gene products, human immunodeficiency virus - genetics |
2 |
polymerase chain reaction -methods |
2 |
population surveillance |
2 |
porcine reproductive and respiratory syndrome - diagnosis - epidemiology - immunology |
2 |
porcine respiratory and reproductive syndrome virus - immunology - isolation & purification |
2 |
pp65 assay |
2 |
ppiase domain |
2 |
practice guidelines |
2 |
pregnancy complications, infectious - epidemiology - virology |
2 |
propionibacterium - isolation & purification - pathogenicity |
2 |
propionibacterium avidum |
2 |
prostheses and implants - microbiology |
2 |
protease inhibitors |
2 |
protein processing, post-translational |
2 |
protein subunit vaccine |
2 |
protein transport |
2 |
protein-losing enteropathies - complications - etiology |
2 |
pseudomonas infections - complications - metabolism - pathology |
2 |
pseudomonas veronii |
2 |
pulmonary infections |
2 |
pyelonephritis - diagnosis - drug therapy - microbiology |
2 |
quarantine |
2 |
rabbits |
2 |
real-time polymerase chain reaction - methods |
2 |
recombinant proteins |
2 |
recurrence |
2 |
respiration - drug effects |
2 |
respiratory tract infections - drug therapy - virology |
2 |
rhesus monkey |
2 |
rhinosinusitis |
2 |
rhodococcus equi |
2 |
rhodococcus equi - isolation & purification |
2 |
ribonucleoproteins - genetics - metabolism |
2 |
ribosomal |
2 |
rifampicin |
2 |
rifampin - therapeutic use |
2 |
rna |
2 |
rna scaffold |
2 |
rna, bacterial |
2 |
sars virus - growth & development |
2 |
sars virus - isolation & purification - physiology |
2 |
screening methods |
2 |
seawater - microbiology |
2 |
self-adjuvanted |
2 |
sepsis - microbiology |
2 |
septicemia |
2 |
serum hbv dna suppression |
2 |
severe acute respiratory syndrome - complications |
2 |
severe acute respiratory syndrome - complications - drug therapy - radiography |
2 |
severe acute respiratory syndrome - complications - pathology |
2 |
severe acute respiratory syndrome - diagnosis - epidemiology - therapy |
2 |
severe acute respiratory syndrome - diagnosis - epidemiology - transmission - virology |
2 |
severe acute respiratory syndrome - diagnosis - therapy |
2 |
severe acute respiratory syndrome - immunology - physiopathology |
2 |
severe acute respiratory syndrome - metabolism |
2 |
shigella flexneri - drug effects - enzymology - genetics - isolation & purification |
2 |
shock, surgical - complications |
2 |
skates (fish) |
2 |
soft tissue infections - epidemiology - microbiology - transmission |
2 |
staphylococcal infections - epidemiology - microbiology - prevention & control |
2 |
staphylococcal infections - epidemiology - microbiology - transmission |
2 |
staphylococcal skin infections - epidemiology - microbiology - transmission |
2 |
staphylococcus aureus - drug effects |
2 |
staphylococcus aureus - drug effects - genetics |
2 |
staphylococcus aureus - drug effects - isolation & purification |
2 |
statistics, nonparametric |
2 |
steroids - therapeutic use |
2 |
strongyloides stercoralis |
2 |
strongyloidiasis - immunology |
2 |
subcutaneous cellulitis |
2 |
subtype diversity |
2 |
surgical trauma |
2 |
surgical wound infection - microbiology |
2 |
syndrome |
2 |
systemic lupus erythematosus |
2 |
taiwan - epidemiology |
2 |
tattooing |
2 |
terminology |
2 |
therapeutic use |
2 |
thermostable dna polymerase |
2 |
thrombocytopenia - diagnosis - drug therapy |
2 |
tilapia |
2 |
transplant |
2 |
transportation |
2 |
trichostrongylosis - etiology - physiopathology |
2 |
trichostrongylus |
2 |
tropheryma whipplei |
2 |
tuberculosis - blood - complications |
2 |
tuberculosis - drug therapy - epidemiology - etiology |
2 |
tuberculosis, pulmonary - diagnosis |
2 |
tuberculosis, pulmonary - diagnosis - drug therapy |
2 |
tuberculosis, pulmonary - drug therapy - epidemiology |
2 |
tuberculosis, pulmonary - epidemiology |
2 |
upper lrinary tract infection |
2 |
uracil-n-glycosylase |
2 |
vaccines, attenuated |
2 |
vaccines, inactivated |
2 |
vaccinia virus - genetics |
2 |
ventilation system |
2 |
vibrio |
2 |
vibrio infections |
2 |
vibrio infections - complications - diagnosis - therapy |
2 |
vibrionaceae - classification - isolation & purification |
2 |
viral entry |
2 |
viral envelope proteins - analysis - chemistry - metabolism |
2 |
viral envelope proteins - biosynthesis - genetics |
2 |
viral envelope proteins - chemistry - genetics - immunology |
2 |
viral load monitoring |
2 |
viral matrix proteins - blood |
2 |
viral nonstructural proteins - metabolism |
2 |
viral vaccines - administration & dosage |
2 |
virulence factor |
2 |
weight gain |
2 |
whipple’s disease |
2 |
whole-body irradiation |
2 |
wound healing - drug effects |
2 |
wound infection - microbiology |
2 |
wound infection - pathology |
2 |
yeasts - genetics - metabolism |
2 |
zoonoses-transmission |
2 |
acute kidney injury - complications |
1 |
acyclovir - administration & dosage - therapeutic use |
1 |
aids-related opportunistic infections - diagnosis - immunology - microbiology |
1 |
air conditioning |
1 |
ambulatory care |
1 |
aminoglycosides |
1 |
amoxicillin - therapeutic use |
1 |
animals, wild |
1 |
anti-bacterial agents - administration & dosage - adverse effects - pharmacokinetics |
1 |
antibodies, fungal - biosynthesis - immunology |
1 |
antibodies, monoclonal |
1 |
antibodies, monoclonal - biosynthesis - immunology |
1 |
antibodies, viral |
1 |
anticoagulants - therapeutic use |
1 |
antigens, bacterial - isolation & purification |
1 |
antigens, fungal - immunology |
1 |
antigens, surface - genetics - immunology - metabolism |
1 |
antigens, surface - isolation & purification |
1 |
antigens, viral |
1 |
antiviral agents - chemical synthesis - pharmacology |
1 |
antivirals |
1 |
artificial ventilation |
1 |
asthma - complications |
1 |
asymptomatic individuals |
1 |
avian influenza a(h7n9) virus |
1 |
bacteria-growth-and-development |
1 |
bacterial infections - drug therapy |
1 |
bacteriophages - genetics |
1 |
beta-lactam resistance |
1 |
beta-lactamases - antagonists & inhibitors |
1 |
beta-lactamases - antagonists & inhibitors - metabolism |
1 |
beta-lactams |
1 |
biological markers |
1 |
biopsy, needle |
1 |
biosafety |
1 |
bioterrorism - history |
1 |
brain stem - pathology |
1 |
bronchial diseases - microbiology |
1 |
brucellosis |
1 |
campylobacter |
1 |
campylobacter fetus |
1 |
campylobacter infections - complications - congenital - transmission |
1 |
campylobacter infections - diagnosis |
1 |
campylobacter pylori |
1 |
candida tropicalis |
1 |
candidiasis - epidemiology - microbiology |
1 |
capsule |
1 |
carbohydrate sequence |
1 |
central nervous system infections - complications - diagnosis - virology |
1 |
cerebellum - pathology |
1 |
clpi |
1 |
communicable diseases - drug therapy - enzymology |
1 |
communicable diseases, emerging - epidemiology |
1 |
communication |
1 |
confidence intervals |
1 |
coronavirinae |
1 |
coronavirus - enzymology |
1 |
coronaviruses |
1 |
cox proportional hazdard model |
1 |
cross infection - diagnosis - epidemiology - microbiology - prevention & control |
1 |
cross infection - prevention & control |
1 |
cross infection - prevention & control - transmission |
1 |
cryptococcus |
1 |
ctd |
1 |
cysteine - pharmacology |
1 |
cysteine endopeptidases - chemistry - metabolism |
1 |
cysteine proteinase inhibitors - chemical synthesis - pharmacology |
1 |
data collection |
1 |
database management systems |
1 |
dengue - diagnosis - virology |
1 |
dengue virus - isolation & purification |
1 |
diabetes mellitus |
1 |
disease outbreaks - history |
1 |
disposable-equipment-standards |
1 |
disseminated infection |
1 |
drug administration schedule |
1 |
drug carriers |
1 |
drug design |
1 |
drug resistant |
1 |
duodenal-ulcer-microbiology |
1 |
education, nursing - methods |
1 |
electrophoresis, polyacrylamide gel |
1 |
encephalitis - drug therapy - microbiology |
1 |
enzyme inhibitors - pharmacology - therapeutic use |
1 |
enzyme inhibitors - therapeutic use |
1 |
equipment-contamination |
1 |
escherichia coli - drug effects - immunology |
1 |
escherichia coli infections - complications - microbiology |
1 |
evaluation studies as topic |
1 |
extensively drug-resistant bacteria |
1 |
extracorporeal circulation |
1 |
extracorporeal membrane oxygenation - methods |
1 |
false positive reactions |
1 |
fluconazole |
1 |
fluoroquinolone |
1 |
fungal proteins - analysis - blood - genetics |
1 |
gastritis - diagnosis - microbiology |
1 |
gastroscopy |
1 |
genome, viral - genetics |
1 |
glasgow coma scale |
1 |
glucocorticoids - administration & dosage |
1 |
hand washing |
1 |
health care personnel |
1 |
health care system |
1 |
health personnel |
1 |
helicobacter-infections-complications |
1 |
helicobacter-pylori |
1 |
hemagglutinins, viral - genetics |
1 |
herpes zoster - drug therapy |
1 |
history, 19th century |
1 |
history, 21st century |
1 |
hospital bed capacity, 500 and over |
1 |
hospital management |
1 |
hospital units |
1 |
hospitals, public |
1 |
hospitals, teaching |
1 |
human novel influenza a (h1n1) virus |
1 |
hybridomas - immunology |
1 |
hygiene - education |
1 |
immunoassay |
1 |
immunocompetent host |
1 |
immunoglobulin m - blood |
1 |
immunoglobulins, intravenous - adverse effects |
1 |
immunostaining |
1 |
infection - diagnosis - drug therapy |
1 |
infectious disease transmission, patient-to-professional |
1 |
influenza a virus - pathogenicity - physiology |
1 |
influenza a virus, h1n1 subtype |
1 |
influenza a virus, h1n1 subtype - chemistry - genetics |
1 |
influenza a virus, h1n1 subtype - isolation & purification |
1 |
influenza a virus, h5n1 subtype - growth & development - immunology |
1 |
influenza in birds - epidemiology - transmission |
1 |
influenza vaccines - administration & dosage - adverse effects - immunology |
1 |
influenza, human |
1 |
influenza, human - complications - pathology |
1 |
influenza, human - complications - therapy |
1 |
influenza, human - diagnosis - therapy - transmission - virology |
1 |
inservice training - methods |
1 |
interferon-gamma - metabolism |
1 |
interleukins - metabolism |
1 |
interprofessional relations |
1 |
ipd meta-analysis |
1 |
k-nearest neighbour algorithm |
1 |
kidney calculi - complications |
1 |
kidney failure, chronic - complications - therapy |
1 |
laboratories |
1 |
laboratory management |
1 |
laboratory-based immunoassays for sars-cov-2 detection |
1 |
latex fixation tests |
1 |
laundry |
1 |
leadership |
1 |
leukoencephalitis, acute hemorrhagic - etiology - pathology |
1 |
linens |
1 |
liposomes |
1 |
logistic regression |
1 |
lung diseases - microbiology |
1 |
lung diseases, obstructive - complications |
1 |
lymphopenia - complications |
1 |
mastectomy, modified radical |
1 |
medicine |
1 |
membrane glycoproteins - analysis - blood - genetics |
1 |
membrane glycoproteins - immunology - physiology |
1 |
methicillin-resistant staphylococcus aureus (mrsa) |
1 |
methylprednisolone - administration & dosage |
1 |
methylprednisolone - therapeutic use |
1 |
molecular biology - methods |
1 |
molecular diagnostic techniques |
1 |
molecular structure |
1 |
moraxella (branhamella) catarrhalis - drug effects |
1 |
moraxella (branhamella) catarrhalis - isolation & purification - pathogenicity |
1 |
mucormycosis |
1 |
mucormycosis - complications - drug therapy - microbiology |
1 |
multi-fluorescent real-time rt-pcr |
1 |
multivariate survival analysis |
1 |
mycobacterium - genetics - isolation & purification |
1 |
mycobacterium tuberculosis - classification - genetics - isolation & purification |
1 |
mycoses - complications |
1 |
nebulizers-and-vaporizers-standards |
1 |
neisseria - isolation & purification |
1 |
neonatal infection |
1 |
new drugs |
1 |
nonstructural proteins |
1 |
nucleocapsid - blood |
1 |
nucleocapsid proteins - blood |
1 |
oligonucleotide array sequence analysis |
1 |
oligopeptides - chemical synthesis - pharmacology |
1 |
opportunistic infections - etiology |
1 |
orthopedics |
1 |
oxazoles - chemical synthesis - pharmacology |
1 |
oxygenators, membrane |
1 |
pandemic influenza |
1 |
pandemic vaccine |
1 |
penicillin resistance |
1 |
penicillium - immunology |
1 |
penicillium - immunology - isolation & purification |
1 |
peptide fragments - immunology |
1 |
peritoneal dialysis, continuous ambulatory |
1 |
peritonitis - epidemiology - microbiology |
1 |
peritonitis - etiology |
1 |
phase i/ii |
1 |
placenta consumption |
1 |
plague - history |
1 |
pneumococcal infections - drug therapy |
1 |
pneumonia - drug therapy - microbiology |
1 |
point-of-care immunoassays for sars-cov-2 detection |
1 |
pre-pandemic vaccine |
1 |
pregnancy complications, infectious |
1 |
pregnancy complications, infectious - virology |
1 |
primary gastritis |
1 |
probability |
1 |
problem solving |
1 |
prognostication |
1 |
protective devices |
1 |
protein structure, quaternary |
1 |
pulmonary embolism - drug therapy - radiography - virology |
1 |
pyrrolidinones - chemical synthesis - pharmacology |
1 |
randomized controlled trials as topic |
1 |
rapid detection |
1 |
rapid urease test |
1 |
receptors, virus - chemistry |
1 |
recombinant proteins - immunology - isolation & purification - metabolism |
1 |
reliability theory |
1 |
respiratory distress syndrome, adult - epidemiology - mortality - therapy |
1 |
respiratory tract infections - microbiology |
1 |
rna-binding proteins - chemistry - genetics - metabolism |
1 |
sars virus - chemistry - genetics - metabolism |
1 |
sars virus - genetics - immunology - metabolism |
1 |
sars-cov-2 antigen rapid detection tests |
1 |
scarlet fever |
1 |
selection (genetics) |
1 |
sepsis - complications - epidemiology - microbiology |
1 |
sepsis - complications - microbiology |
1 |
sequence homology |
1 |
serum - virology |
1 |
severe acute respiratory syndrome - blood - virology |
1 |
severe acute respiratory syndrome - complications - virology |
1 |
severe acute respiratory syndrome - drug therapy - physiopathology |
1 |
severe acute respiratory syndrome - epidemiology |
1 |
severe acute respiratory syndrome - epidemiology - immunology - |
1 |
severe acute respiratory syndrome - transmission - virology |
1 |
severe acute respiratory syndrome coronavirus 2 (sars-cov-2) |
1 |
severe acute respiratory syndrome-associated coronavirus |
1 |
signal processing, computer-assisted |
1 |
singapore |
1 |
social distancing |
1 |
specialization |
1 |
staff roster |
1 |
staphylococcal infections - diagnosis - epidemiology - microbiology - prevention & control |
1 |
static electricity |
1 |
steptococcus pyogenes |
1 |
sterilization-standards |
1 |
streptococcal infections - complications - epidemiology - microbiology |
1 |
streptococcus |
1 |
structure |
1 |
superantigen |
1 |
surgical-wound-infection-diagnosis |
1 |
thalamus - pathology |
1 |
tomography, x-ray computed - methods |
1 |
transmissible gastroenteritis virus - enzymology |
1 |
trichosporon |
1 |
tuberculosis,-pulmonary-diagnosis |
1 |
tumor necrosis factor-alpha - metabolism |
1 |
urease - diagnostic use |
1 |
urinary catheterization - standards |
1 |
urinary tract infections - complications - microbiology |
1 |
vaccination - adverse effects - methods |
1 |
viral envelope proteins - immunology - physiology |
1 |
viral nonstructural proteins - blood |
1 |
viral pneumonia |
1 |
viral proteins - antagonists & inhibitors |
1 |
weil disease - radiography |
1 |
wet-warming |
1 |
wound healing - physiology |
1 |
zygomycosis |
1 |